46 results on '"Trieu HT"'
Search Results
2. COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study
- Author
-
Abdukahil, SA, Abe, R, Abel, L, Absil, L, Acker, A, Adachi, S, Adam, E, Adriao, D, Ainscough, K, Hssain, AA, Tamlihat, YA, Akimoto, T, Al-Dabbous, T, Al-Fares, A, Al Qasim, E, Alalqam, R, Alex, B, Alexandre, K, Alfoudri, H, Alidjnou, KE, Aliudin, J, Allavena, C, Allou, N, Alves, J, Alves, R, Amaral, M, Ammerlaan, H, Ampaw, P, Andini, R, Andrejak, C, Angheben, A, Angoulvant, F, Ansart, S, Antonelli, M, De Brito, CAA, Arabi, Y, Aragao, I, Arcadipane, A, Arenz, L, Arlet, J-B, Arnold-Day, C, Arora, L, Artaud-Macari, E, Asensio, A, Assie, JB, Atique, A, Auchabie, J, Aumaitre, H, Azemar, L, Azoulay, C, Bach, B, Bachelet, D, Baillie, JK, Bak, E, Bakakos, A, Banisadr, F, Barbalho, R, Barclay, WS, Barnikel, M, Barrelet, A, Barrigoto, C, Basmaci, R, Rincon, DFB, Bedossa, A, Behilill, S, Beljantsev, A, Bellemare, D, Beltrame, A, Beluze, M, Benech, N, Benkerrou, D, Bennett, S, Bento, L, Berdal, J-E, Bergeaud, D, Bertolino, L, Bessis, S, Bevilcaqua, S, Bhavsar, K, Bin Humaid, F, Bissuel, F, Biston, P, Bitker, L, Blanco-Schweizer, P, Blot, M, Boccia, F, Bogaert, D, Bompart, F, Booth, G, Borges, D, Borie, R, Bos, J, Bosse, HM, Botelho-Nevers, E, Bouadma, L, Bouchaud, O, Bouchez, S, Bouhmani, D, Bouhour, D, Bouiller, K, Bouillet, L, Bouisse, C, Boureau, A-S, Bouscambert, M, Bouziotis, J, Boxma, B, Boyer-Besseyre, M, Boylan, M, Braga, C, Brandenburger, T, Brazzi, L, Breen, D, Breen, P, Brickell, K, Brozzi, N, Buchtele, N, Buesaquillo, C, Bugaeva, P, Buisson, M, Burhan, E, Bustos, IG, Butnaru, D, Carcel, S, Cabie, A, Cabral, S, Caceres, E, Callahan, M, Calligy, K, Calvache, JA, Camoes, J, Campana, V, Campbell, P, Canepa, C, Cantero, M, Caraux-Paz, P, Cardoso, F, Cardoso, S, Carelli, S, Carlier, N, Carney, G, Carpenter, C, Carret, M-C, Carrier, FM, Carson, G, Casanova, M-L, Cascao, M, Casimiro, J, Cassandra, B, Castaneda, S, Castanheira, N, Castor-Alexandre, G, Castrillon, H, Castro, I, Catarino, A, Catherine, F-X, Cavalin, R, Cavalli, GG, Cavayas, A, Ceccato, A, Cervantes-Gonzalez, M, Chair, A, Chakveatze, C, Chan, A, Chand, M, Chas, J, Chassin, C, Chen, A, Chen, Y-S, Cheng, MP, Cheret, A, Chiarabini, T, Chica, J, Chirouze, C, Chiumello, D, Cho, HJ, Cho, SM, Cholley, B, Cidade, JP, Herreros, JMC, Citarella, BW, Ciullo, A, Clarke, J, Clohisey, S, Codan, C, Cody, C, Coelho, A, Colin, G, Collins, M, Colombo, SM, Combs, P, Connelly, JP, Connor, M, Conrad, A, Contreras, S, Cooke, GS, Copland, M, Cordel, H, Corley, A, Cormican, S, Cornelis, S, Corpuz, AJ, Corvaisier, G, Couffignal, C, Couffin-Cadiergues, S, Courtois, R, D'Orleans, CC, Croonen, S, Crowl, G, Crump, J, Cruz, C, Csete, M, Cucino, A, Cullen, C, Cummings, M, Curley, G, Curlier, E, Custodio, P, D'Aragon, F, Filipe, ADS, Da Silveira, C, D'Ortenzio, E, Dabaliz, A-A, Dagens, AB, Dalton, H, Dalton, J, Daneman, N, Dankwa, EA, Dantas, J, De Castro, N, De Mendoza, D, Franca, RFDO, De Rosa, R, De Silva, T, De Vries, P, Dean, D, Debray, M-P, Dechert, W, Deconninck, L, Decours, R, Delacroix, I, Delavigne, K, Deligiannis, I, Dell'amore, A, Delobel, P, Demonchy, E, Denis, E, Deplanque, D, Depuydt, P, Desai, M, Descamps, D, Desvallee, M, Dewayanti, SR, Diallo, A, Diamantis, S, Dias, A, Diaz, JJD, Diaz, R, Didier, K, Diehl, J-L, Dieperink, W, Dimet, J, Dinot, V, Diouf, A, Dishon, Y, Djossou, F, Docherty, AB, Dong, A, Donnelly, CA, Donnelly, M, Donohue, C, Dorival, C, Douglas, JJ, Douma, R, Dournon, N, Downer, T, Downing, M, Drake, T, Dubee, V, Dubos, F, Ducancelle, A, Dudman, S, Dunning, J, Mangoni, ED, Duranti, S, Durham, L, Dussol, B, Duval, X, Dyrhol-Riise, AM, Eira, C, Vidal, JE, El Sanharawi, M, Elapavaluru, S, Elharrar, B, Elkheir, N, Ellerbroek, J, Ellis, R, Eloy, P, Elshazly, T, Enderle, I, Engelmann, I, Enouf, V, Epaulard, O, Esperatti, M, Esperou, H, Esposito-Farese, M, Estevao, J, Etienne, M, Ettalhaoui, N, Everding, AG, Evers, M, Fabre, I, Faheem, A, Fahy, A, Fairfield, CJ, Faria, P, Farshait, N, Fatoni, AZ, Faure, K, Fayed, M, Feely, N, Fernandes, J, Fernandes, M, Fernandes, S, Ferrao, J, Devouge, EF, Ferraz, M, Ferreira, B, Ferrer-Roca, R, Figueiredo-Mello, C, Flateau, C, Fletcher, T, Florio, LL, Foley, C, Fomin, V, Fonseca, CD, Fonseca, T, Fontela, P, Forsyth, S, Foti, G, Fourn, E, Fowler, R, Franch-Llasat, D, Fraser, C, Fraser, J, Freire, MV, Ribeiro, AF, Friedrich, C, Fry, S, Fuentes, N, Fukuda, M, Gomez-Junyent, J, Gaborieau, V, Gachet, B, Gaci, R, Gagliardi, M, Gagnard, J-C, Gagneux-Brunon, A, Gaiao, S, Gallagher, P, Curto, EG, Gamble, C, Garan, A, Garcia-Gallo, E, Garcia, R, Garot, D, Garrait, V, Gault, N, Gavin, A, Gaymard, A, Gebauer, J, Morlaes, LG, Germano, N, Ghosn, J, Giani, M, Giaquinto, C, Gibson, J, Gigante, T, Gilg, M, Giordano, G, Girvan, M, Gissot, V, Giwangkancana, G, Glikman, D, Glybochko, P, Gnall, E, Goco, G, Goehringer, F, Goepel, S, Goffard, J-C, Golob, J, Gorenne, I, Goujard, C, Goulenok, T, Grable, M, Grandin, EW, Granier, P, Grasselli, G, Green, CA, Greenhalf, W, Greffe, S, Grieco, DL, Griffee, M, Griffiths, F, Grigoras, I, Groenendijk, A, Lordemann, AG, Gruner, H, Gu, Y, Guedj, J, Guellec, D, Guerguerian, A-M, Guerreiro, D, Guery, R, Guillaumot, A, Guilleminault, L, Guimard, T, Haber, D, Hakak, S, Hall, M, Halpin, S, Hamer, A, Hamidfar, R, Hammond, T, Hardwick, H, Harley, K, Harrison, EM, Harrison, J, Hays, L, Heerman, J, Heggelund, L, Hendry, R, Hennessy, M, Henriquez-Trujillo, A, Hentzien, M, Hernandez-Montfort, J, Hidayah, A, Higgins, D, Higgins, E, Hinton, S, Hipolito-Reis, A, Hiraiwa, H, Hiscox, JA, Ho, AYW, Hoctin, A, Hoffmann, I, Hoiting, O, Holt, R, Holter, JC, Horby, P, Horcajada, JP, Hoshino, K, Hough, CL, Hsu, JM-Y, Hulot, J-S, Ijaz, S, Illes, H-G, Inacio, H, Dominguez, CI, Iosifidis, E, Irvine, L, Isgett, S, Isidoro, T, Isnard, M, Itai, J, Ivulich, D, Jaafoura, S, Jabot, J, Jackson, C, Jamieson, N, Jaureguiberry, S, Javidfar, J, Jean-Benoit, Z, Jego, F, Jenum, S, Sotomayor, RJ, Garcia, RNJ, Joseph, C, Joseph, M, Jouvet, P, Jung, H, Kafif, O, Kaguelidou, F, Kali, S, Kalomoiri, S, Kandamby, DH, Kandel, C, Kant, R, Kartsonaki, C, Kasugai, D, Katz, K, Johal, SK, Keating, S, Kelly, A, Kelly, S, Kennedy, L, Kennon, K, Kerroumi, Y, Kestelyn, E, Khalid, I, Khalil, A, Khan, C, Khan, I, Kho, ME, Khoo, S, Kida, Y, Kiiza, P, Kildal, AB, Kimmoun, A, Kindgen-Milles, D, Kitamura, N, Klenerman, P, Bekken, GK, Knight, S, Kobbe, R, Vasconcelos, MK, Korten, V, Kosgei, C, Krawczyk, K, Vecham, PK, Kumar, D, Kurtzman, E, Kutsogiannis, D, Kyriakoulis, K, L'her, E, Lachatre, M, Lacoste, M, Laffey, JG, Lagrange, M, Laine, F, Lambert, M, Lamontagne, F, Langelot-Richard, M, Lantang, EY, Lanza, M, Laouenan, C, Laribi, S, Lariviere, D, Launay, O, Lavie-Badie, Y, Law, A, Le Bihan, C, Le Bris, C, Le Coustumier, E, Le Falher, G, Le Gac, S, Le Hingrat, Q, Le Marechal, M, Le Mestre, S, Le Moing, V, Le Nagard, H, Le Turnier, P, Leon, R, Le, M, Santos, ML, Leal, E, Lee, J, Lee, SH, Lee, T, Leeming, G, Lefebvre, B, Lefebvre, L, Lefevre, B, Lellouche, F, Lemaignen, A, Lemee, V, Lemmink, G, Leone, M, Lepiller, Q, Lescure, F-X, Lesens, O, Lesouhaitier, M, Levy-Marchal, C, Levy, B, Levy, Y, Bassi, GL, Liang, J, Lim, WS, Lina, B, Lind, A, Lingas, G, Lion-Daolio, S, Liu, K, Loforte, A, Lolong, N, Lopes, D, Lopez-Colon, D, Loubet, P, Lucet, JC, Luna, CM, Lungu, O, Luong, L, Luton, D, Lyons, R, Mueller, F, Mueller, KE, Maasikas, O, Macdonald, S, Machado, M, Macheda, G, Sanchez, JM, Madhok, J, Mahieu, R, Mahy, S, Maier, LS, Maillet, M, Maitre, T, Malfertheiner, M, Malik, N, Maltez, F, Malvy, D, Mambert, M, Manda, V, Mandei, JM, Manning, E, Manuel, A, Malaque, CMSA, Marino, F, Mariz, CDA, Eid, CM, Marques, A, Marquis, C, Marsh, B, Marsh, L, Marshall, J, Martelli, CT, Martin-Blondel, G, Martin-Loeches, I, Martin-Quiros, A, Martin, D-A, Martin, E, Martinot, M, Rego, CM, Martins, A, Martins, J, Martucci, G, Marwali, EM, Jimenez, JFM, Maslove, D, Mason, S, Matan, M, Mathieu, D, Mattei, M, Matulevics, R, Maulin, L, Mc Evoy, N, McCarthy, A, McCloskey, C, McConnochie, R, McDermott, S, McDonald, S, McElwee, S, McEvoy, N, McGeer, A, McGuinness, N, McLean, KA, McNicholas, B, Meaney, E, Mear-Passard, C, Mechlin, M, Mele, F, Menon, K, Mentre, F, Mentzer, AJ, Mercier, N, Merckx, A, Mergler, B, Merson, L, Mesquita, A, Meybeck, A, Meynert, AM, Meyssonnier, V, Meziane, A, Mezidi, M, Michelanglei, C, Mihnovits, V, Maldonado, HM, Mone, M, Moin, A, Molina, D, Molinos, E, Monteiro, A, Montes, C, Montrucchio, G, Moore, S, Moore, SC, Morales-Cely, L, Moro, L, Tutillo, DRM, Motos, A, Mouquet, H, Perrot, CM, Moyet, J, Mullaert, J, Munblit, D, Murphy, D, Murris, M, Myrodia, DM, N'guyen, Y, Neant, N, Neb, H, Nekliudov, NA, Neto, R, Neumann, E, Neves, B, Ng, PY, Ng, WY, Choileain, ON, Nichol, A, Nonas, S, Noret, M, Norman, L, Notari, A, Noursadeghi, M, Nowicka, K, Nseir, S, Nunez, JI, Nyamankolly, E, O'Donnell, M, O'Hearn, K, O'Neil, C, Occhipinti, G, Ogston, T, Ogura, T, Oh, T-H, Ohshimo, S, Oinam, BCS, Oliveira, AP, Oliveira, J, Olliaro, P, Ong, DSY, Oosthuyzen, W, Openshaw, PJM, Orozco-Chamorro, CM, Orquera, A, Osatnik, J, Ouamara, N, Ouissa, R, Owyang, C, Oziol, E, Povoas, D, Pagadoy, M, Pages, J, Palacios, M, Palmarini, M, Panarello, G, Panda, PK, Panigada, M, Pansu, N, Papadopoulos, A, Parra, B, Pasquier, J, Patauner, F, Patrao, L, Paul, C, Paul, M, Paulos, J, Paxton, WA, Payen, J-F, Pearse, I, Peek, GJ, Peelman, F, Peiffer-Smadja, N, Peigne, V, Pejkovska, M, Peltan, ID, Pereira, R, Perez, D, Perpoint, T, Pesenti, A, Petrousova, L, Petrov-Sanchez, V, Peytavin, G, Pharand, S, Piagnerelli, M, Picard, W, Picone, O, Piel-Julian, M, Pierobon, C, Pimentel, C, Piroth, L, Pius, R, Piva, S, Plantier, L, Plotkin, D, Poissy, J, Pokorska-Spiewak, M, Poli, S, Pollakis, G, Popielska, J, Postma, DF, Povoa, P, Powis, J, Prapa, S, Prebensen, C, Preiser, J-C, Prestre, V, Price, N, Prinssen, A, Pritchard, MG, Proenca, L, Puechal, O, Purcell, G, Quesada, L, Quist-Paulsen, E, Quraishi, M, Ratsep, I, Rossler, B, Rabaud, C, Rafiq, M, Ragazzo, G, Rainieri, F, Ramakrishnan, N, Ramanathan, K, Rammaert, B, Rapp, C, Rasmin, M, Rau, C, Rebaudet, S, Redl, S, Reeve, B, Reid, L, Reis, R, Remppis, J, Remy, M, Renk, H, Resende, L, Resseguier, A-S, Revest, M, Rewa, O, Reyes, LF, Richardson, D, Richier, L, Riera, J, Rios, AL, Rishu, A, Rispal, P, Risso, K, Nunez, MAR, Rizer, N, Roberto, A, Roberts, S, Robertson, DL, Robineau, O, Roche-Campo, F, Rodari, P, Rodeia, S, Abreu, JR, Roilides, E, Rojek, A, Romaru, J, Roncon-Albuquerque, R, Roriz, M, Rosa-Calatrava, M, Rose, M, Rosenberger, D, Rossanese, A, Rossignol, B, Rossignol, P, Roy, C, Roze, B, Russell, CD, Ryckaert, S, Holten, AR, Choez, XS, Saba, I, Sadat, M, Saidani, N, Salazar, L, Sales, G, Sallaberry, S, Salvator, H, Sanchez-Miralles, A, Sanchez, O, Sancho-Shimizu, V, Sandhu, G, Sandulescu, O, Santos, M, Sarfo-Mensah, S, Sarton, B, Saviciute, E, Savvidou, P, Scarsbrook, J, Schermer, T, Scherpereel, A, Schneider, M, Schroll, S, Schwameis, M, Scott-Brown, J, Scott, JT, Sedillot, N, Seitz, T, Semaille, C, Semple, MG, Senneville, E, Sequeira, F, Sequeira, T, Shadowitz, E, Shamsah, M, Sharma, P, Shaw, CA, Shaw, V, Shiban, N, Shime, N, Shimizu, H, Shimizu, K, Shrapnel, S, Shum, HP, Mohammed, NS, Sigfrid, L, Silva, C, Silva, MJ, Sin, WC, Skogen, V, Smith, S, Smood, B, Smyth, M, Snacken, M, So, D, Solis, M, Solomon, J, Solomon, T, Somers, E, Sommet, A, Song, MJ, Song, R, Song, T, Sonntagbauer, M, Soum, E, Uva, MS, Sousa, M, Souza-Dantas, V, Sperry, A, Sriskandan, S, Staudinger, T, Stecher, S-S, Stienstra, Y, Stiksrud, B, Streinu-Cercel, A, Strudwick, S, Stuart, A, Stuart, D, Sultana, A, Summers, C, Surovcova, M, Svistunov, AA, Syrigos, K, Sztajnbok, J, Szuldrzynski, K, Teoule, F, Tabrizi, S, Tagherset, L, Talarek, E, Taleb, S, Talsma, J, Van Tan, L, Tanaka, H, Tanaka, T, Taniguchi, H, Tardivon, C, Tattevin, P, Taufik, MA, Tedder, RS, Teixeira, J, Tellier, M-C, Terpstra, P, Terrier, O, Terzi, N, Tessier-Grenier, H, Thibault, V, Thiberville, S-D, Thill, B, Thompson, AAR, Thompson, S, Thomson, D, Thomson, EC, Thuy, DB, Thwaites, RS, Timashev, PS, Timsit, J-F, Vijayaraghavan, BKT, Toki, M, Tonby, K, Santos-Olmo, RMT, Torres, A, Torres, M, Trioux, T, Trieu, HT, Tromeur, C, Trontzas, I, Troost, J, Trouillon, T, Tual, C, Tubiana, S, Tuite, H, Turtle, LCW, Twardowski, P, Uchiyama, M, Ullrich, R, Uribe, A, Usman, A, Val-Flores, L, Van de Velde, S, Van den Berge, M, Van der Feltz, M, Van der Vekens, N, Van der Voort, P, Van der Werf, S, Van Dyk, M, Van Gulik, L, Van Hattem, J, Van Lelyveld, S, Van Netten, C, Vanel, N, Vanoverschelde, H, Vauchy, C, Veislinger, A, Velazco, J, Ventura, S, Verbon, A, Vieira, C, Villanueva, JA, Villar, J, Villeneuve, P-M, Villoldo, A, Chau, NVV, Visseaux, B, Visser, H, Vuorinen, A, Vuotto, F, Wang, C-H, Wei, J, Weil, K, Wesselius, S, Wham, M, Whelan, B, White, N, Wiedemann, A, Wille, K, Wils, E-J, Xynogalas, I, Suen, JY, Yacoub, S, Yamazaki, M, Yazdanpanah, Y, Yelnik, C, Yerkovich, S, Yokoyama, T, Yonis, H, Young, P, Yuliarto, S, Zabbe, M, Zacharowski, K, Zahran, M, Zambon, M, Zanella, A, Zawadka, K, Zayyad, H, Zoufaly, A, Zucman, D, Abdukahil, SA, Abe, R, Abel, L, Absil, L, Acker, A, Adachi, S, Adam, E, Adriao, D, Ainscough, K, Hssain, AA, Tamlihat, YA, Akimoto, T, Al-Dabbous, T, Al-Fares, A, Al Qasim, E, Alalqam, R, Alex, B, Alexandre, K, Alfoudri, H, Alidjnou, KE, Aliudin, J, Allavena, C, Allou, N, Alves, J, Alves, R, Amaral, M, Ammerlaan, H, Ampaw, P, Andini, R, Andrejak, C, Angheben, A, Angoulvant, F, Ansart, S, Antonelli, M, De Brito, CAA, Arabi, Y, Aragao, I, Arcadipane, A, Arenz, L, Arlet, J-B, Arnold-Day, C, Arora, L, Artaud-Macari, E, Asensio, A, Assie, JB, Atique, A, Auchabie, J, Aumaitre, H, Azemar, L, Azoulay, C, Bach, B, Bachelet, D, Baillie, JK, Bak, E, Bakakos, A, Banisadr, F, Barbalho, R, Barclay, WS, Barnikel, M, Barrelet, A, Barrigoto, C, Basmaci, R, Rincon, DFB, Bedossa, A, Behilill, S, Beljantsev, A, Bellemare, D, Beltrame, A, Beluze, M, Benech, N, Benkerrou, D, Bennett, S, Bento, L, Berdal, J-E, Bergeaud, D, Bertolino, L, Bessis, S, Bevilcaqua, S, Bhavsar, K, Bin Humaid, F, Bissuel, F, Biston, P, Bitker, L, Blanco-Schweizer, P, Blot, M, Boccia, F, Bogaert, D, Bompart, F, Booth, G, Borges, D, Borie, R, Bos, J, Bosse, HM, Botelho-Nevers, E, Bouadma, L, Bouchaud, O, Bouchez, S, Bouhmani, D, Bouhour, D, Bouiller, K, Bouillet, L, Bouisse, C, Boureau, A-S, Bouscambert, M, Bouziotis, J, Boxma, B, Boyer-Besseyre, M, Boylan, M, Braga, C, Brandenburger, T, Brazzi, L, Breen, D, Breen, P, Brickell, K, Brozzi, N, Buchtele, N, Buesaquillo, C, Bugaeva, P, Buisson, M, Burhan, E, Bustos, IG, Butnaru, D, Carcel, S, Cabie, A, Cabral, S, Caceres, E, Callahan, M, Calligy, K, Calvache, JA, Camoes, J, Campana, V, Campbell, P, Canepa, C, Cantero, M, Caraux-Paz, P, Cardoso, F, Cardoso, S, Carelli, S, Carlier, N, Carney, G, Carpenter, C, Carret, M-C, Carrier, FM, Carson, G, Casanova, M-L, Cascao, M, Casimiro, J, Cassandra, B, Castaneda, S, Castanheira, N, Castor-Alexandre, G, Castrillon, H, Castro, I, Catarino, A, Catherine, F-X, Cavalin, R, Cavalli, GG, Cavayas, A, Ceccato, A, Cervantes-Gonzalez, M, Chair, A, Chakveatze, C, Chan, A, Chand, M, Chas, J, Chassin, C, Chen, A, Chen, Y-S, Cheng, MP, Cheret, A, Chiarabini, T, Chica, J, Chirouze, C, Chiumello, D, Cho, HJ, Cho, SM, Cholley, B, Cidade, JP, Herreros, JMC, Citarella, BW, Ciullo, A, Clarke, J, Clohisey, S, Codan, C, Cody, C, Coelho, A, Colin, G, Collins, M, Colombo, SM, Combs, P, Connelly, JP, Connor, M, Conrad, A, Contreras, S, Cooke, GS, Copland, M, Cordel, H, Corley, A, Cormican, S, Cornelis, S, Corpuz, AJ, Corvaisier, G, Couffignal, C, Couffin-Cadiergues, S, Courtois, R, D'Orleans, CC, Croonen, S, Crowl, G, Crump, J, Cruz, C, Csete, M, Cucino, A, Cullen, C, Cummings, M, Curley, G, Curlier, E, Custodio, P, D'Aragon, F, Filipe, ADS, Da Silveira, C, D'Ortenzio, E, Dabaliz, A-A, Dagens, AB, Dalton, H, Dalton, J, Daneman, N, Dankwa, EA, Dantas, J, De Castro, N, De Mendoza, D, Franca, RFDO, De Rosa, R, De Silva, T, De Vries, P, Dean, D, Debray, M-P, Dechert, W, Deconninck, L, Decours, R, Delacroix, I, Delavigne, K, Deligiannis, I, Dell'amore, A, Delobel, P, Demonchy, E, Denis, E, Deplanque, D, Depuydt, P, Desai, M, Descamps, D, Desvallee, M, Dewayanti, SR, Diallo, A, Diamantis, S, Dias, A, Diaz, JJD, Diaz, R, Didier, K, Diehl, J-L, Dieperink, W, Dimet, J, Dinot, V, Diouf, A, Dishon, Y, Djossou, F, Docherty, AB, Dong, A, Donnelly, CA, Donnelly, M, Donohue, C, Dorival, C, Douglas, JJ, Douma, R, Dournon, N, Downer, T, Downing, M, Drake, T, Dubee, V, Dubos, F, Ducancelle, A, Dudman, S, Dunning, J, Mangoni, ED, Duranti, S, Durham, L, Dussol, B, Duval, X, Dyrhol-Riise, AM, Eira, C, Vidal, JE, El Sanharawi, M, Elapavaluru, S, Elharrar, B, Elkheir, N, Ellerbroek, J, Ellis, R, Eloy, P, Elshazly, T, Enderle, I, Engelmann, I, Enouf, V, Epaulard, O, Esperatti, M, Esperou, H, Esposito-Farese, M, Estevao, J, Etienne, M, Ettalhaoui, N, Everding, AG, Evers, M, Fabre, I, Faheem, A, Fahy, A, Fairfield, CJ, Faria, P, Farshait, N, Fatoni, AZ, Faure, K, Fayed, M, Feely, N, Fernandes, J, Fernandes, M, Fernandes, S, Ferrao, J, Devouge, EF, Ferraz, M, Ferreira, B, Ferrer-Roca, R, Figueiredo-Mello, C, Flateau, C, Fletcher, T, Florio, LL, Foley, C, Fomin, V, Fonseca, CD, Fonseca, T, Fontela, P, Forsyth, S, Foti, G, Fourn, E, Fowler, R, Franch-Llasat, D, Fraser, C, Fraser, J, Freire, MV, Ribeiro, AF, Friedrich, C, Fry, S, Fuentes, N, Fukuda, M, Gomez-Junyent, J, Gaborieau, V, Gachet, B, Gaci, R, Gagliardi, M, Gagnard, J-C, Gagneux-Brunon, A, Gaiao, S, Gallagher, P, Curto, EG, Gamble, C, Garan, A, Garcia-Gallo, E, Garcia, R, Garot, D, Garrait, V, Gault, N, Gavin, A, Gaymard, A, Gebauer, J, Morlaes, LG, Germano, N, Ghosn, J, Giani, M, Giaquinto, C, Gibson, J, Gigante, T, Gilg, M, Giordano, G, Girvan, M, Gissot, V, Giwangkancana, G, Glikman, D, Glybochko, P, Gnall, E, Goco, G, Goehringer, F, Goepel, S, Goffard, J-C, Golob, J, Gorenne, I, Goujard, C, Goulenok, T, Grable, M, Grandin, EW, Granier, P, Grasselli, G, Green, CA, Greenhalf, W, Greffe, S, Grieco, DL, Griffee, M, Griffiths, F, Grigoras, I, Groenendijk, A, Lordemann, AG, Gruner, H, Gu, Y, Guedj, J, Guellec, D, Guerguerian, A-M, Guerreiro, D, Guery, R, Guillaumot, A, Guilleminault, L, Guimard, T, Haber, D, Hakak, S, Hall, M, Halpin, S, Hamer, A, Hamidfar, R, Hammond, T, Hardwick, H, Harley, K, Harrison, EM, Harrison, J, Hays, L, Heerman, J, Heggelund, L, Hendry, R, Hennessy, M, Henriquez-Trujillo, A, Hentzien, M, Hernandez-Montfort, J, Hidayah, A, Higgins, D, Higgins, E, Hinton, S, Hipolito-Reis, A, Hiraiwa, H, Hiscox, JA, Ho, AYW, Hoctin, A, Hoffmann, I, Hoiting, O, Holt, R, Holter, JC, Horby, P, Horcajada, JP, Hoshino, K, Hough, CL, Hsu, JM-Y, Hulot, J-S, Ijaz, S, Illes, H-G, Inacio, H, Dominguez, CI, Iosifidis, E, Irvine, L, Isgett, S, Isidoro, T, Isnard, M, Itai, J, Ivulich, D, Jaafoura, S, Jabot, J, Jackson, C, Jamieson, N, Jaureguiberry, S, Javidfar, J, Jean-Benoit, Z, Jego, F, Jenum, S, Sotomayor, RJ, Garcia, RNJ, Joseph, C, Joseph, M, Jouvet, P, Jung, H, Kafif, O, Kaguelidou, F, Kali, S, Kalomoiri, S, Kandamby, DH, Kandel, C, Kant, R, Kartsonaki, C, Kasugai, D, Katz, K, Johal, SK, Keating, S, Kelly, A, Kelly, S, Kennedy, L, Kennon, K, Kerroumi, Y, Kestelyn, E, Khalid, I, Khalil, A, Khan, C, Khan, I, Kho, ME, Khoo, S, Kida, Y, Kiiza, P, Kildal, AB, Kimmoun, A, Kindgen-Milles, D, Kitamura, N, Klenerman, P, Bekken, GK, Knight, S, Kobbe, R, Vasconcelos, MK, Korten, V, Kosgei, C, Krawczyk, K, Vecham, PK, Kumar, D, Kurtzman, E, Kutsogiannis, D, Kyriakoulis, K, L'her, E, Lachatre, M, Lacoste, M, Laffey, JG, Lagrange, M, Laine, F, Lambert, M, Lamontagne, F, Langelot-Richard, M, Lantang, EY, Lanza, M, Laouenan, C, Laribi, S, Lariviere, D, Launay, O, Lavie-Badie, Y, Law, A, Le Bihan, C, Le Bris, C, Le Coustumier, E, Le Falher, G, Le Gac, S, Le Hingrat, Q, Le Marechal, M, Le Mestre, S, Le Moing, V, Le Nagard, H, Le Turnier, P, Leon, R, Le, M, Santos, ML, Leal, E, Lee, J, Lee, SH, Lee, T, Leeming, G, Lefebvre, B, Lefebvre, L, Lefevre, B, Lellouche, F, Lemaignen, A, Lemee, V, Lemmink, G, Leone, M, Lepiller, Q, Lescure, F-X, Lesens, O, Lesouhaitier, M, Levy-Marchal, C, Levy, B, Levy, Y, Bassi, GL, Liang, J, Lim, WS, Lina, B, Lind, A, Lingas, G, Lion-Daolio, S, Liu, K, Loforte, A, Lolong, N, Lopes, D, Lopez-Colon, D, Loubet, P, Lucet, JC, Luna, CM, Lungu, O, Luong, L, Luton, D, Lyons, R, Mueller, F, Mueller, KE, Maasikas, O, Macdonald, S, Machado, M, Macheda, G, Sanchez, JM, Madhok, J, Mahieu, R, Mahy, S, Maier, LS, Maillet, M, Maitre, T, Malfertheiner, M, Malik, N, Maltez, F, Malvy, D, Mambert, M, Manda, V, Mandei, JM, Manning, E, Manuel, A, Malaque, CMSA, Marino, F, Mariz, CDA, Eid, CM, Marques, A, Marquis, C, Marsh, B, Marsh, L, Marshall, J, Martelli, CT, Martin-Blondel, G, Martin-Loeches, I, Martin-Quiros, A, Martin, D-A, Martin, E, Martinot, M, Rego, CM, Martins, A, Martins, J, Martucci, G, Marwali, EM, Jimenez, JFM, Maslove, D, Mason, S, Matan, M, Mathieu, D, Mattei, M, Matulevics, R, Maulin, L, Mc Evoy, N, McCarthy, A, McCloskey, C, McConnochie, R, McDermott, S, McDonald, S, McElwee, S, McEvoy, N, McGeer, A, McGuinness, N, McLean, KA, McNicholas, B, Meaney, E, Mear-Passard, C, Mechlin, M, Mele, F, Menon, K, Mentre, F, Mentzer, AJ, Mercier, N, Merckx, A, Mergler, B, Merson, L, Mesquita, A, Meybeck, A, Meynert, AM, Meyssonnier, V, Meziane, A, Mezidi, M, Michelanglei, C, Mihnovits, V, Maldonado, HM, Mone, M, Moin, A, Molina, D, Molinos, E, Monteiro, A, Montes, C, Montrucchio, G, Moore, S, Moore, SC, Morales-Cely, L, Moro, L, Tutillo, DRM, Motos, A, Mouquet, H, Perrot, CM, Moyet, J, Mullaert, J, Munblit, D, Murphy, D, Murris, M, Myrodia, DM, N'guyen, Y, Neant, N, Neb, H, Nekliudov, NA, Neto, R, Neumann, E, Neves, B, Ng, PY, Ng, WY, Choileain, ON, Nichol, A, Nonas, S, Noret, M, Norman, L, Notari, A, Noursadeghi, M, Nowicka, K, Nseir, S, Nunez, JI, Nyamankolly, E, O'Donnell, M, O'Hearn, K, O'Neil, C, Occhipinti, G, Ogston, T, Ogura, T, Oh, T-H, Ohshimo, S, Oinam, BCS, Oliveira, AP, Oliveira, J, Olliaro, P, Ong, DSY, Oosthuyzen, W, Openshaw, PJM, Orozco-Chamorro, CM, Orquera, A, Osatnik, J, Ouamara, N, Ouissa, R, Owyang, C, Oziol, E, Povoas, D, Pagadoy, M, Pages, J, Palacios, M, Palmarini, M, Panarello, G, Panda, PK, Panigada, M, Pansu, N, Papadopoulos, A, Parra, B, Pasquier, J, Patauner, F, Patrao, L, Paul, C, Paul, M, Paulos, J, Paxton, WA, Payen, J-F, Pearse, I, Peek, GJ, Peelman, F, Peiffer-Smadja, N, Peigne, V, Pejkovska, M, Peltan, ID, Pereira, R, Perez, D, Perpoint, T, Pesenti, A, Petrousova, L, Petrov-Sanchez, V, Peytavin, G, Pharand, S, Piagnerelli, M, Picard, W, Picone, O, Piel-Julian, M, Pierobon, C, Pimentel, C, Piroth, L, Pius, R, Piva, S, Plantier, L, Plotkin, D, Poissy, J, Pokorska-Spiewak, M, Poli, S, Pollakis, G, Popielska, J, Postma, DF, Povoa, P, Powis, J, Prapa, S, Prebensen, C, Preiser, J-C, Prestre, V, Price, N, Prinssen, A, Pritchard, MG, Proenca, L, Puechal, O, Purcell, G, Quesada, L, Quist-Paulsen, E, Quraishi, M, Ratsep, I, Rossler, B, Rabaud, C, Rafiq, M, Ragazzo, G, Rainieri, F, Ramakrishnan, N, Ramanathan, K, Rammaert, B, Rapp, C, Rasmin, M, Rau, C, Rebaudet, S, Redl, S, Reeve, B, Reid, L, Reis, R, Remppis, J, Remy, M, Renk, H, Resende, L, Resseguier, A-S, Revest, M, Rewa, O, Reyes, LF, Richardson, D, Richier, L, Riera, J, Rios, AL, Rishu, A, Rispal, P, Risso, K, Nunez, MAR, Rizer, N, Roberto, A, Roberts, S, Robertson, DL, Robineau, O, Roche-Campo, F, Rodari, P, Rodeia, S, Abreu, JR, Roilides, E, Rojek, A, Romaru, J, Roncon-Albuquerque, R, Roriz, M, Rosa-Calatrava, M, Rose, M, Rosenberger, D, Rossanese, A, Rossignol, B, Rossignol, P, Roy, C, Roze, B, Russell, CD, Ryckaert, S, Holten, AR, Choez, XS, Saba, I, Sadat, M, Saidani, N, Salazar, L, Sales, G, Sallaberry, S, Salvator, H, Sanchez-Miralles, A, Sanchez, O, Sancho-Shimizu, V, Sandhu, G, Sandulescu, O, Santos, M, Sarfo-Mensah, S, Sarton, B, Saviciute, E, Savvidou, P, Scarsbrook, J, Schermer, T, Scherpereel, A, Schneider, M, Schroll, S, Schwameis, M, Scott-Brown, J, Scott, JT, Sedillot, N, Seitz, T, Semaille, C, Semple, MG, Senneville, E, Sequeira, F, Sequeira, T, Shadowitz, E, Shamsah, M, Sharma, P, Shaw, CA, Shaw, V, Shiban, N, Shime, N, Shimizu, H, Shimizu, K, Shrapnel, S, Shum, HP, Mohammed, NS, Sigfrid, L, Silva, C, Silva, MJ, Sin, WC, Skogen, V, Smith, S, Smood, B, Smyth, M, Snacken, M, So, D, Solis, M, Solomon, J, Solomon, T, Somers, E, Sommet, A, Song, MJ, Song, R, Song, T, Sonntagbauer, M, Soum, E, Uva, MS, Sousa, M, Souza-Dantas, V, Sperry, A, Sriskandan, S, Staudinger, T, Stecher, S-S, Stienstra, Y, Stiksrud, B, Streinu-Cercel, A, Strudwick, S, Stuart, A, Stuart, D, Sultana, A, Summers, C, Surovcova, M, Svistunov, AA, Syrigos, K, Sztajnbok, J, Szuldrzynski, K, Teoule, F, Tabrizi, S, Tagherset, L, Talarek, E, Taleb, S, Talsma, J, Van Tan, L, Tanaka, H, Tanaka, T, Taniguchi, H, Tardivon, C, Tattevin, P, Taufik, MA, Tedder, RS, Teixeira, J, Tellier, M-C, Terpstra, P, Terrier, O, Terzi, N, Tessier-Grenier, H, Thibault, V, Thiberville, S-D, Thill, B, Thompson, AAR, Thompson, S, Thomson, D, Thomson, EC, Thuy, DB, Thwaites, RS, Timashev, PS, Timsit, J-F, Vijayaraghavan, BKT, Toki, M, Tonby, K, Santos-Olmo, RMT, Torres, A, Torres, M, Trioux, T, Trieu, HT, Tromeur, C, Trontzas, I, Troost, J, Trouillon, T, Tual, C, Tubiana, S, Tuite, H, Turtle, LCW, Twardowski, P, Uchiyama, M, Ullrich, R, Uribe, A, Usman, A, Val-Flores, L, Van de Velde, S, Van den Berge, M, Van der Feltz, M, Van der Vekens, N, Van der Voort, P, Van der Werf, S, Van Dyk, M, Van Gulik, L, Van Hattem, J, Van Lelyveld, S, Van Netten, C, Vanel, N, Vanoverschelde, H, Vauchy, C, Veislinger, A, Velazco, J, Ventura, S, Verbon, A, Vieira, C, Villanueva, JA, Villar, J, Villeneuve, P-M, Villoldo, A, Chau, NVV, Visseaux, B, Visser, H, Vuorinen, A, Vuotto, F, Wang, C-H, Wei, J, Weil, K, Wesselius, S, Wham, M, Whelan, B, White, N, Wiedemann, A, Wille, K, Wils, E-J, Xynogalas, I, Suen, JY, Yacoub, S, Yamazaki, M, Yazdanpanah, Y, Yelnik, C, Yerkovich, S, Yokoyama, T, Yonis, H, Young, P, Yuliarto, S, Zabbe, M, Zacharowski, K, Zahran, M, Zambon, M, Zanella, A, Zawadka, K, Zayyad, H, Zoufaly, A, and Zucman, D
- Abstract
BACKGROUND: The ISARIC prospective multinational observational study is the largest cohort of hospitalized patients with COVID-19. We present relationships of age, sex, and nationality to presenting symptoms. METHODS: International, prospective observational study of 60 109 hospitalized symptomatic patients with laboratory-confirmed COVID-19 recruited from 43 countries between 30 January and 3 August 2020. Logistic regression was performed to evaluate relationships of age and sex to published COVID-19 case definitions and the most commonly reported symptoms. RESULTS: 'Typical' symptoms of fever (69%), cough (68%) and shortness of breath (66%) were the most commonly reported. 92% of patients experienced at least one of these. Prevalence of typical symptoms was greatest in 30- to 60-year-olds (respectively 80, 79, 69%; at least one 95%). They were reported less frequently in children (≤ 18 years: 69, 48, 23; 85%), older adults (≥ 70 years: 61, 62, 65; 90%), and women (66, 66, 64; 90%; vs. men 71, 70, 67; 93%, each P < 0.001). The most common atypical presentations under 60 years of age were nausea and vomiting and abdominal pain, and over 60 years was confusion. Regression models showed significant differences in symptoms with sex, age and country. INTERPRETATION: This international collaboration has allowed us to report reliable symptom data from the largest cohort of patients admitted to hospital with COVID-19. Adults over 60 and children admitted to hospital with COVID-19 are less likely to present with typical symptoms. Nausea and vomiting are common atypical presentations under 30 years. Confusion is a frequent atypical presentation of COVID-19 in adults over 60 years. Women are less likely to experience typical symptoms than men.
- Published
- 2021
3. Cardio-haemodynamic assessment and venous lactate in severe dengue: Relationship with recurrent shock and respiratory distress
- Author
-
Rothman, AL, Yacoub, S, Trieu, HT, Phung, KL, Vuong, HNT, Duong, HTH, Tu, QP, Oanh, PKN, Nguyen, THQ, Simmons, CP, Broyd, C, Screaton, GR, Wills, B, Rothman, AL, Yacoub, S, Trieu, HT, Phung, KL, Vuong, HNT, Duong, HTH, Tu, QP, Oanh, PKN, Nguyen, THQ, Simmons, CP, Broyd, C, Screaton, GR, and Wills, B
- Abstract
BACKGROUND: Dengue can cause plasma leakage that may lead to dengue shock syndrome (DSS). In approximately 30% of DSS cases, recurrent episodes of shock occur. These patients have a higher risk of fluid overload, respiratory distress and poor outcomes. We investigated the association of echocardiographically-derived cardiac function and intravascular volume parameters plus lactate levels, with the outcomes of recurrent shock and respiratory distress in severe dengue. METHODS/PRINCIPLE FINDINGS: We performed a prospective observational study in Paediatric and adult ICU, at the Hospital for Tropical Diseases (HTD), Ho Chi Minh City, Vietnam. Patients with dengue were enrolled within 12 hours of admission to paediatric or adult ICU. A haemodynamic assessment and portable echocardiograms were carried out daily for 5 days from enrolment and all interventions recorded. 102 patients were enrolled; 22 patients did not develop DSS, 48 had a single episode of shock and 32 had recurrent shock. Patients with recurrent shock had a higher enrolment pulse than those with 1 episode or no shock (median: 114 vs. 100 vs. 100 b/min, P = 0.002), significantly lower Stroke Volume Index (SVI), (median: 21.6 vs. 22.8 vs. 26.8mls/m2, P<0.001) and higher lactate levels (4.2 vs. 2.9 vs. 2.2 mmol/l, P = 0.001). Higher SVI and worse left ventricular function (higher Left Myocardial Performance Index) on study days 3-5 was associated with the secondary endpoint of respiratory distress. There was an association between the total IV fluid administered during the ICU admission and respiratory distress (OR: 1.03, 95% CI 1.01-1.06, P = 0.001). Admission lactate levels predicted patients who subsequently developed recurrent shock (P = 0.004), and correlated positively with the total IV fluid volume received (rho: 0.323, P = 0.001) and also with admission ALT (rho: 0.764, P<0.001) and AST (rho: 0.773, P<0.001). CONCLUSIONS/SIGNIFICANCE: Echo-derived intravascular volume assessment and venous lactate le
- Published
- 2017
4. Adaptive shared control strategies based in the Bayesian recursive technique in an intelligent wheelchair
- Author
-
Trieu, HT, Willey, K, Nguyen, HT, Trieu, HT, Willey, K, and Nguyen, HT
- Abstract
In this paper we present an adaptive shared control method for an intelligent wheelchair based on the Bayesian recursive technique to assist a disable user in performing obstacle avoidance tasks. Three autonomous tasks have been developed for different types of environments to improve the performance of the overall system. The system combines local environmental information gathered using a laser range finder sensor with the user's intentions to select the most suitable autonomous task in different situations. The evidences of these tasks are estimated by the Bayesian recursive technique during movements of the wheelchair. The most appropriate task is chosen to be the with the highest evidence value. Experimental results show significant performance improvements compared to our previously reported shared control methods. ©2009 IEEE.
- Published
- 2009
5. Shared control strategies for obstacle avoidance tasks in an intelligent wheelchair.
- Author
-
Trieu, HT, Nguyen, HT, Willey, K, Trieu, HT, Nguyen, HT, and Willey, K
- Abstract
In this paper we present a method of shared control strategy for an intelligent wheelchair to assist a disable user in performing obstacle avoidance tasks. The system detects obstacles in front of the wheelchair using a laser range finder sensor. As the wheelchair moves the information from the laser range finder is combined with data from the encoders mounted in its driving wheels to build a 360 degrees real-time map. The accuracy of the map is improved by eliminating the systematic error that would result from both the uncertainty of effective wheelbase and unequal driving wheel diameters. The usable wheelchair accessible space is determined by including the actual wheelchair dimensions in producing the real-time map. In making a decision the shared control method considers the user's intentions via the head-movement interface, accessible space of the environment and user safety. The experiments show promising results in the intelligent wheelchair system.
- Published
- 2008
6. Advanced obstacle avoidance for a laser based wheelchair using optimised Bayesian neural networks.
- Author
-
Trieu, HT, Nguyen, HT, Willey, K, Trieu, HT, Nguyen, HT, and Willey, K
- Abstract
In this paper we present an advanced method of obstacle avoidance for a laser based intelligent wheelchair using optimized Bayesian neural networks. Three neural networks are designed for three separate sub-tasks: passing through a door way, corridor and wall following and general obstacle avoidance. The accurate usable accessible space is determined by including the actual wheelchair dimensions in a real-time map used as inputs to each networks. Data acquisitions are performed separately to collect the patterns required for specified sub-tasks. Bayesian frame work is used to determine the optimal neural network structure in each case. Then these networks are trained under the supervision of Bayesian rule. Experiment results showed that compare to the VFH algorithm our neural networks navigated a smoother path following a near optimum trajectory.
- Published
- 2008
7. Obstacle avoidance for power wheelchair using bayesian neural network.
- Author
-
Trieu, HT, Nguyen, HT, Willey, K, Trieu, HT, Nguyen, HT, and Willey, K
- Abstract
In this paper we present a real-time obstacle avoidance algorithm using a Bayesian neural network for a laser based wheelchair system. The raw laser data is modified to accommodate the wheelchair dimensions, allowing the free-space to be determined accurately in real-time. Data acquisition is performed to collect the patterns required for training the neural network. A Bayesian frame work is applied to determine the optimal neural network structure for the training data. This neural network is trained under the supervision of the Bayesian rule and the obstacle avoidance task is then implemented for the wheelchair system. Initial results suggest this approach provides an effective solution for autonomous tasks, suggesting Bayesian neural networks may be useful for wider assistive technology applications.
- Published
- 2007
8. Phytochemicals, Organic Acid, and Vitamins in Red Rhapsody Strawberry-Content and Storage Stability.
- Author
-
Hong HT, Rami J, Rychlik M, O'Hare TJ, and Netzel ME
- Abstract
Strawberries are highly perishable fruits harvested at full ripeness, and their nutritional quality together with their phytochemical composition can be significantly affected by storage duration and temperature. This study investigated the changes in key bioactive compounds, including folate, vitamin C, anthocyanins, quercetin-3-glucoside, ellagic acid, and organic acids, in "Red Rhapsody" strawberries stored at two typical household temperatures (4 °C and 23 °C). While storage duration and temperature did not have a significant impact ( p > 0.05) on folate content, significant changes in other phytochemicals were observed. The total anthocyanin content increased significantly ( p < 0.05), from 30.0 mg/100 g fresh weight (FW) at Day 0 to 84.4 mg/100 g FW at Day 7 at 23 °C, a 2.8-fold increase. Conversely, the vitamin C content was significantly reduced ( p < 0.05), from 54.1 mg/100 g FW at Day 0 to 28.4 mg/100 g FW at Day 7 at 23 °C, while it remained stable at 4 °C. Additionally, the concentrations of quercetin-3-glucoside, ellagic acid, and organic acids underwent significant changes during the storage period. The total folate content fluctuated between 73.2 and 81.6 μg/100 g FW at both temperatures. These results suggest that storage temperature and duration influence the individual phytochemicals and nutrients of strawberries differently, with potential implications for their nutritional value and bioactive compound content.
- Published
- 2025
- Full Text
- View/download PDF
9. Assessment of the ability of Lactococcus lactis 537 to bind aflatoxin M1 in the presence of inulin and Terminalia ferdinandiana (Kakadu plum).
- Author
-
Almutairi B, Fletcher MT, Hong HT, Dong A, Turner MS, and Sultanbawa Y
- Subjects
- Probiotics metabolism, Prebiotics, Animals, Food Contamination analysis, Food Contamination prevention & control, Fruit microbiology, Fruit chemistry, Inulin metabolism, Inulin chemistry, Lactococcus lactis metabolism, Aflatoxin M1 metabolism, Milk microbiology, Milk chemistry, Terminalia chemistry
- Abstract
One promising method for the detoxification of Aflatoxin M1 (AFM1) involves the use of probiotic bacteria combined with prebiotics. This approach is both safe and cost-effective, while also offering additional health benefits. The objective of this study was to investigate the capacity of Lactococcus lactis 537 (Lc. Lactis 537) to bind AFM1 in milk and phosphate-buffered saline (PBS), either in the presence or absence of inulin or Kakadu plum fruit powder (KP), which are prebiotic substances. Lc. Lactis 537 was incubated for 0, 1, 2, and 24 h at 30 °C, with or without inulin or KP, to assess its ability to bind and reduce AFM1 levels. The concentration of AFM1 was determined using liquid chromatography-mass spectrometry (LC-MS9) during the different incubation periods. The results demonstrated that Lc. Lactis 537 significantly reduced the initial concentration of AFM1 in both milk and PBS after 24 h of incubation. Moreover, the presence of inulin or KP enhanced the binding and reduction capacity of Lc. Lactis 537. This suggests that the synbiotic effect where probiotic bacteria like Lc. Lactis work in synergy with prebiotics such as inulin or KP could play a critical role in the removal of AFM1 from contaminated substances. In conclusion, the synbiotic of Lc. Lactis 537 with inulin or KP represents a promising biological approach for AFM1 detoxification, and further research is warranted to explore its potential applications in food safety., Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Yasmina Sultanbawa reports financial support was provided by The university of Queensland. Batlah Almutairi reports financial support was provided by Kuwait Institute for Scientific Research., (Crown Copyright © 2024. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2025
- Full Text
- View/download PDF
10. Anakinra for dengue patients with hyperinflammation: protocol for a randomized double-blind placebo-controlled trial.
- Author
-
Huyen TB, Trieu HT, Vuong NL, Minh Nguyet N, Tam DTH, McBride A, Linh NTM, Thuan DT, Phong NT, Trung TN, Huong NTC, Vien TTD, Duyen HTL, Hoa VTM, Watson J, Geskus R, Tho PV, Kestelyn E, Qui PT, and Yacoub S
- Abstract
Background: Novel host-directed therapies are urgently needed for patients with dengue, particularly those at high risk of developing severe disease. Broad immunosuppression using corticosteroids in unselected patients with dengue has so far been unsuccessful. Patients with hyperinflammation (raised CRP and/or ferritin levels) are at highest risk of poor outcomes in dengue. Anakinra is a licensed, bio-engineered form of the naturally occurring IL-1R antagonist which has shown efficacy in other acute viral-associated hyperinflammatory syndromes., Methods: This is a randomized placebo-controlled phase II trial of anakinra in 160 patients ≥ 12 years old, diagnosed as having dengue with warning signs or severe dengue and the hyperinflammatory syndrome (plasma ferritin >2000 ng/ml). Participants will receive a 4-day course of either anakinra or placebo. The primary endpoint is the efficacy of anakinra measured by the delta mSOFA score* (change in mSOFA score over 4 days after randomization). The accompanying immunological and transcriptomic analyses aim to identify novel mechanisms and pathways that may represent future biomarkers and therapeutic targets., Discussion: The observed immunomodulatory benefit of anakinra in acute viral-associated hyperinflammatory syndromes including COVID-19 and auto-immune diseases makes this medication a promising potential treatment for dengue patients with hyperinflammation. This trial will assess the safety and efficacy of anakinra in patients with severe dengue or at high risk of developing life-threatening dengue disease., Registration: ClinicalTrials.gov (NCT05611710)., Competing Interests: No competing interests were disclosed., (Copyright: © 2024 Huyen TB et al.)
- Published
- 2024
- Full Text
- View/download PDF
11. Predicting deterioration in dengue using a low cost wearable for continuous clinical monitoring.
- Author
-
Ming DK, Daniels J, Chanh HQ, Karolcik S, Hernandez B, Manginas V, Nguyen VH, Nguyen QH, Phan TQ, Luong THT, Trieu HT, Holmes AH, Phan VT, Georgiou P, and Yacoub S
- Abstract
Close vital signs monitoring is crucial for the clinical management of patients with dengue. We investigated performance of a non-invasive wearable utilising photoplethysmography (PPG), to provide real-time risk prediction in hospitalised individuals. We performed a prospective observational clinical study in Vietnam between January 2020 and October 2022: 153 patients were included in analyses, providing 1353 h of PPG data. Using a multi-modal transformer approach, 10-min PPG waveform segments and basic clinical data (age, sex, clinical features on admission) were used as features to continuously forecast clinical state 2 h ahead. Prediction of low-risk states (17,939/80,843; 22.1%), defined by NEWS2 and mSOFA < 6, was associated with an area under the precision-recall curve of 0.67 and an area under the receiver operator curve of 0.83. Implementation of such interventions could provide cost-effective triage and clinical care in dengue, offering opportunities for safe ambulatory patient management., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
12. Corrigendum to "Sargassum horneri extracts stimulate innate immunity, enhance growth performance, and upregulate immune genes in the white shrimp Litopenaeus vannamei" [Fish Shellfish Immunol. 102 (2020) 276-285].
- Author
-
Lee PT, Quan Tran HT, Huang HT, Nan FH, and Lee MC
- Published
- 2024
- Full Text
- View/download PDF
13. Benchmarking Bulb Yield, Medicinal Sulfur Compounds, and Mineral Nutrition of Garlic Varieties.
- Author
-
Nguyen BT, Wehr JB, Kopittke PM, O'Hare TJ, Menzies NW, Hong HT, McKenna BA, Klysubun W, and Harper SM
- Abstract
Garlic is widely cultivated for both its culinary and medicinal properties. Bulb yield, organosulfur compounds, and plant mineral nutrition of 32 garlic varieties were characterized. Across genotypes, there was large variability in bulb weight and alliin and allicin concentrations. The mineral concentration of a reference leaf was strongly positively correlated with bulb weight (for Zn, N, and K) and bulb allicin concentration (for S, Mo, and Cu). Alliin represented ∼61 and 88% of the total clove S content. In situ synchrotron-based X-ray absorption near-edge structure (XANES) analysis identified two dominant S compounds, γ-l-glutamyl- S -allyl-l-cysteine and alliin. Stoichiometric studies showed the ratio of conversion of alliin to pyruvate was consistently below the theoretical 1:1 ratio, while the ratio for conversion of alliin to allicin was consistently higher (∼1.9:1 to 3.5:1). A combination of optimized fertilizer management and genotype selection for high alliin can potentially substantially increase the yield and medicinal quality of garlic., Competing Interests: The authors declare no competing financial interest., (© 2024 The Authors. Published by American Chemical Society.)
- Published
- 2024
- Full Text
- View/download PDF
14. Storage Effects on the Physicochemical Properties, Phytochemical Composition, and Sugars in Red-Fleshed Cultivars, 'Rubycot' Plumcot, and 'Queen Garnet' Plum.
- Author
-
Kodagoda GK, Hong HT, O'Hare TJ, Topp B, Sultanbawa Y, and Netzel ME
- Subjects
- Food Storage, Phenols analysis, Phenols chemistry, Prunus domestica chemistry, Temperature, Carotenoids analysis, Carotenoids chemistry, Chemical Phenomena, Quercetin analysis, Quercetin chemistry, Phytochemicals chemistry, Phytochemicals analysis, Fruit chemistry, Anthocyanins analysis, Anthocyanins chemistry, Sugars analysis
- Abstract
Domestic storage conditions can have a significant impact on the composition of phytochemicals and sugars in stone fruits. This study aimed to evaluate the effect of two domestic storage temperatures (4 and 23 °C) on the physicochemical properties, phytochemical composition, and sugars of 'Rubycot' (RC) plumcot, a novel stone fruit variety, and 'Queen Garnet' (QG) plum. Initially, RC had a lower total anthocyanin concentration (TAC) than QG, but TAC in RC increased significantly ( p < 0.05) during storage, peaking at +95% after 7 days at 23 °C, while QG reached +60% after 14 days. At 4 °C, TAC increased for both varieties (RC +30%, QG +27%). RC had a higher initial total phenolic content (TPC), which also increased for both fruits. QG had a significantly higher initial total quercetin concentration (TQC), increasing by 40% ( p < 0.05) at 23 °C. The initial total carotenoid concentration in QG was higher than that in RC, but after 10 days at 23 °C, RC had a higher carotenoid concentration than QG. Both varieties showed similar sugar profiles, with QG starting higher but decreasing over time at both storage temperatures. Results from this study showed that ambient storage significantly increases total anthocyanins, total quercetins, and TPC in RC and QG. However, it is important to evaluate the textural and sensory properties of stored RC and QG in terms of consumer acceptability of the stored fruits.
- Published
- 2024
- Full Text
- View/download PDF
15. Exploring the potential of CoMoO 4 -modified graphitic carbon nitride to boost oxidation of amoxicillin micropollutants in hospital wastewater.
- Author
-
Thi HP, Bui TH, Nguyen MV, Nguyen MP, Hien Chu TT, and Nguyen HT
- Subjects
- Photolysis, Hospitals, Nitrogen Compounds chemistry, Catalysis, Water Purification methods, Amoxicillin chemistry, Wastewater chemistry, Graphite chemistry, Water Pollutants, Chemical chemistry, Oxidation-Reduction
- Abstract
This study investigates the removal of amoxicillin micropollutants (AM) from hospital wastewater using CoMoO
4 -modified graphitic carbon nitride (CMO/gCN). Consequently, CMO/gCN exhibits notable improvements in visible light absorption and electron-hole separation rates compared to unmodified gCN. Besides, CMO/gCN significantly enhances the removal efficiency of AM, attaining an impressive 96.5%, far surpassing the performance of gCN at 48.6%. Moreover, CMO/gCN showcases outstanding reusability, with AM degradation performance exceeding 70% even after undergoing six cycles of reuse. The removal mechanism of AM employing CMO/gCN involves various photoreactions of radicals (•OH, •O2 - ) and amoxicillin molecules under light assistance. Furthermore, CMO/gCN demonstrates a noteworthy photodegradation efficiency of AM from hospital wastewater, reaching 92.8%, with a near-complete reduction in total organic carbon levels. Detailed discussions on the practical applications of the CMO/gCN photocatalyst for removal of micropollutants from hospital wastewater are provided. These findings underline the considerable potential of CMO/gCN for effectively removing various pollutants in environmental remediation strategies., (© 2024. The Author(s), under exclusive licence to Springer Nature B.V.)- Published
- 2024
- Full Text
- View/download PDF
16. Kinetics of cardiovascular and inflammatory biomarkers in paediatric dengue shock syndrome.
- Author
-
Chanh HQ, Trieu HT, Tran Kim H, Huynh Ngoc Thien V, Huyen VNT, Moncada A, Thanh Nguyen Thi K, Duyen HTL, Nguyen-Lyle N, Vuong NL, Lam PK, McBride A, Phan TQ, Dong Thi Hoai T, Wills B, and Yacoub S
- Abstract
Glycocalyx disruption and hyperinflammatory responses are implicated in the pathogenesis of dengue-associated vascular leak, however little is known about their association with clinical outcomes of patients with dengue shock syndrome (DSS). We investigated the association of vascular and inflammatory biomarkers with clinical outcomes and their correlations with clinical markers of vascular leakage. We performed a prospective cohort study in Viet Nam. Children ≥5 years of age with a clinical diagnosis of DSS were enrolled into this study. Blood samples were taken daily during ICU stay and 7-10 days after hospital discharge for measurements of plasma levels of Syndecan-1, Hyaluronan, Suppression of tumourigenicity 2 (ST-2), Ferritin, N-terminal pro Brain Natriuretic Peptide (NT-proBNP), and Atrial Natriuretic Peptide (ANP). The primary outcome was recurrent shock. Ninety DSS patients were enrolled. Recurrent shock occurred in 16 patients. All biomarkers, except NT-proBNP, were elevated at presentation with shock. There were no differences between compensated and decompensated DSS patients. Glycocalyx markers were positively correlated with inflammatory biomarkers, haematocrit, percentage haemoconcentration, and negatively correlated with stroke volume index. While Syndecan-1, Hyaluronan, Ferritin, and ST-2 improved with time, ANP continued to be raised at follow-up. Enrolment Syndecan-1 levels were observed to be associated with developing recurrent shock although the association did not reach the statistical significance at the P < 0.01 (OR = 1.82, 95% CI 1.07-3.35, P = 0.038). Cardiovascular and inflammatory biomarkers are elevated in DSS, correlate with clinical vascular leakage parameters and follow different kinetics over time. Syndecan-1 may have potential utility in risk stratifying DSS patients in ICU., (© The Author(s) 2024. Published by Oxford University Press.)
- Published
- 2024
- Full Text
- View/download PDF
17. Towards a machine-learning assisted non-invasive classification of dengue severity using wearable PPG data: a prospective clinical study.
- Author
-
Karolcik S, Manginas V, Chanh HQ, Daniels J, Giang NT, Huyen VNT, Hoang MTV, Phan Nguyen Quoc K, Hernandez B, Ming DK, Nguyen Van H, Phan TQ, Trieu HT, Luong Thi Hue T, Holmes AH, Thwaites L, Phan Vinh T, Yacoub S, and Georgiou P
- Subjects
- Humans, Female, Male, Prospective Studies, Adult, Child, Adolescent, Young Adult, Vietnam, Machine Learning, Photoplethysmography methods, Photoplethysmography instrumentation, Severity of Illness Index, Wearable Electronic Devices, Dengue diagnosis
- Abstract
Background: Dengue epidemics impose considerable strain on healthcare resources. Real-time continuous and non-invasive monitoring of patients admitted to the hospital could lead to improved care and outcomes. We evaluated the performance of a commercially available wearable (SmartCare) utilising photoplethysmography (PPG) to stratify clinical risk for a cohort of hospitalised patients with dengue in Vietnam., Methods: We performed a prospective observational study for adult and paediatric patients with a clinical diagnosis of dengue at the Hospital for Tropical Disease, Ho Chi Minh City, Vietnam. Patients underwent PPG monitoring early during admission alongside standard clinical care. PPG waveforms were analysed using machine learning models. Adult patients were classified between 3 severity classes: i) uncomplicated (ward-based), ii) moderate-severe (emergency department-based), and iii) severe (ICU-based). Data from paediatric patients were split into 2 classes: i) severe (during ICU stay) and ii) follow-up (14-21 days after the illness onset). Model performances were evaluated using standard classification metrics and 5-fold stratified cross-validation., Findings: We included PPG and clinical data from 132 adults and 15 paediatric patients with a median age of 28 (IQR, 21-35) and 12 (IQR, 9-13) years respectively. 1781 h of PPG data were available for analysis. The best performing convolutional neural network models (CNN) achieved a precision of 0.785 and recall of 0.771 in classifying adult patients according to severity class and a precision of 0.891 and recall of 0.891 in classifying between disease and post-disease state in paediatric patients., Interpretation: We demonstrate that the use of a low-cost wearable provided clinically actionable data to differentiate between patients with dengue of varying severity. Continuous monitoring and connectivity to early warning systems could significantly benefit clinical care in dengue, particularly within an endemic setting. Work is currently underway to implement these models for dynamic risk predictions and assist in individualised patient care., Funding: EPSRC Centre for Doctoral Training in High-Performance Embedded and Distributed Systems (HiPEDS) (Grant: EP/L016796/1) and the Wellcome Trust (Grants: 215010/Z/18/Z and 215688/Z/19/Z)., Competing Interests: Declaration of interests The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
18. Pharmacological properties of Ensete glaucum seed extract: Novel insights for antidiabetic effects via modulation of oxidative stress, inflammation, apoptosis and MAPK signaling pathways.
- Author
-
Ly HT, Pham KD, Le PH, Do THT, Nguyen TTH, and Le VM
- Subjects
- Mice, Animals, Humans, MAP Kinase Signaling System, bcl-2-Associated X Protein metabolism, Glyburide pharmacology, Glyburide therapeutic use, alpha-Glucosidases metabolism, Oxidative Stress, Inflammation drug therapy, Glucose metabolism, Signal Transduction, Plant Extracts adverse effects, Proto-Oncogene Proteins c-bcl-2 metabolism, Apoptosis, Seeds metabolism, Hypoglycemic Agents adverse effects, Diabetes Mellitus, Experimental metabolism
- Abstract
Ethnophamacological Relevance: Medicinal plants are increasingly making important contributions to diabetic treatment. Ensete glaucum seeds have been widely used in folk medicine to treat diabetes., Aim of the Study: The study was aimed to investigate the protective effect and active mechanisms of E. glaucum seed extract (EGSE) against streptozotocin (STZ)-induced hyperglycemia., Materials and Methods: Hyperglycemic mice were treated with EGSE (25 and 50 mg/kg) or glibenclamide (5 mg/kg) once daily for 7 d. The effects of these treatments on changes in blood biochemical parameters, pancreatic, liver, and kidney histopathology, oxidative stress and inflammatory marker levels in pancreatic, hepatic, and renal tissues were assessed. Expression of several proteins in MAPK signaling pathway related to apoptosis in pancreatic tissue were investigated. Furthermore, ex vivo, in vitro, and in silico biological activities of EGSE and its compounds were also examined., Results: EGSE and glibenclamide increased notably insulin, reduced significantly glucose, AST, ALT, BUN and creatinine levels in blood. Pancreatic islets, hepatic and renal tissue structure were restored by EGSE or glibenclamide. EGSE showed significant anti-oxidative stress and anti-inflammatory effects by enhancing GSH level and dropping MDA, NF-κB, TNF-α and IL-6 levels in these tissues. Particularly, EGSE exhibited pancreatic protective effect against STZ-induced apoptosis through the MAPK signaling pathway by down-regulation of p-p38 MAPK, ERK1/2, JNK1, p-AMPK, Bax, Bax/Bcl-2, cytochrome c, cleaved-caspase 3 and PARP expression, and slight up-regulation of Bcl-2 expression. Moreover, EGSE inhibited intestinal glucose absorption, PTP1B, α-amylase, and α-glucosidase activities. Its isolated compounds (Afzelechin and coniferaldehyde) showed PTP1B and α-glucosidase inhibitory activities, and potent structure-activity relationships., Conclusion: These findings indicated the hypoglycemic and protective effects of E. glaucum seed extract against the STZ diabetogenic action. E. glaucum seed is a potential candidate for further studies to confirm its activities as a therapeutic agent for diabetic patients., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
19. Applying artificial intelligence and digital health technologies, Viet Nam.
- Author
-
Chanh HQ, Ming DK, Nguyen QH, Duc TM, Phuoc An L, Trieu HT, Karolcik S, Hernandez B, Perez, Van Nuil J, Lyle NN, Kestelyn E, Thwaites L, Georgiou P, Paton C, Holmes A, Van Vinh Chau N, and Yacoub S
- Subjects
- Humans, Vietnam, Risk Factors, Artificial Intelligence, Delivery of Health Care
- Abstract
Problem: Direct application of digital health technologies from high-income settings to low- and middle-income countries may be inappropriate due to challenges around data availability, implementation and regulation. Hence different approaches are needed., Approach: Within the Viet Nam ICU Translational Applications Laboratory project, since 2018 we have been developing a wearable device for individual patient monitoring and a clinical assessment tool to improve dengue disease management. Working closely with local staff at the Hospital for Tropical Diseases, Ho Chi Minh City, we developed and tested a prototype of the wearable device. We obtained perspectives on design and use of the sensor from patients. To develop the assessment tool, we used existing research data sets, mapped workflows and clinical priorities, interviewed stakeholders and held workshops with hospital staff., Local Setting: In Viet Nam, a lower middle-income country, the health-care system is in the nascent stage of implementing digital health technologies., Relevant Changes: Based on patient feedback, we are altering the design of the wearable sensor to increase comfort. We built the user interface of the assessment tool based on the core functionalities selected by workshop attendees. The interface was subsequently tested for usability in an iterative manner by the clinical staff members., Lessons Learnt: The development and implementation of digital health technologies need an interoperable and appropriate plan for data management including collection, sharing and integration. Engagements and implementation studies should be conceptualized and conducted alongside the digital health technology development. The priorities of end-users, and understanding context and regulatory landscape are crucial for success., ((c) 2023 The authors; licensee World Health Organization.)
- Published
- 2023
- Full Text
- View/download PDF
20. A modified Sequential Organ Failure Assessment score for dengue: development, evaluation and proposal for use in clinical trials.
- Author
-
McBride A, Vuong NL, Van Hao N, Huy NQ, Chanh HQ, Chau NTX, Nguyet NM, Ming DK, Ngoc NT, Nhat PTH, Phong NT, Tai LTH, Tho PV, Trung DT, Tam DTH, Trieu HT, Geskus RB, Llewelyn MJ, Thwaites CL, and Yacoub S
- Subjects
- Humans, Intensive Care Units, Multiple Organ Failure, Prognosis, Reproducibility of Results, Retrospective Studies, Tertiary Care Centers, Organ Dysfunction Scores, Severe Dengue
- Abstract
Background: Dengue is a neglected tropical disease, for which no therapeutic agents have shown clinical efficacy to date. Clinical trials have used strikingly variable clinical endpoints, which hampers reproducibility and comparability of findings. We investigated a delta modified Sequential Organ Failure Assessment (delta mSOFA) score as a uniform composite clinical endpoint for use in clinical trials investigating therapeutics for moderate and severe dengue., Methods: We developed a modified SOFA score for dengue, measured and evaluated its performance at baseline and 48 h after enrolment in a prospective observational cohort of 124 adults admitted to a tertiary referral hospital in Vietnam with dengue shock. The modified SOFA score included pulse pressure in the cardiovascular component. Binary logistic regression, cox proportional hazard and linear regression models were used to estimate association between mSOFA, delta mSOFA and clinical outcomes., Results: The analysis included 124 adults with dengue shock. 29 (23.4%) patients required ICU admission for organ support or due to persistent haemodynamic instability: 9/124 (7.3%) required mechanical ventilation, 8/124 (6.5%) required vasopressors, 6/124 (4.8%) required haemofiltration and 5/124 (4.0%) patients died. In univariate analyses, higher baseline and delta (48 h) mSOFA score for dengue were associated with admission to ICU, requirement for organ support and mortality, duration of ICU and hospital admission and IV fluid use., Conclusions: The baseline and delta mSOFA scores for dengue performed well to discriminate patients with dengue shock by clinical outcomes, including duration of ICU and hospital admission, requirement for organ support and death. We plan to use delta mSOFA as the primary endpoint in an upcoming host-directed therapeutic trial and investigate the performance of this score in other phenotypes of severe dengue in adults and children., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
21. Therapeutic Potential of Polyscias fruticosa (L.) Harms Leaf Extract for Parkinson's Disease Treatment by Drosophila melanogaster Model.
- Author
-
Ly HT, Nguyen TTH, Le VM, Lam BT, Mai TTT, and Dang TPT
- Subjects
- Animals, Dopaminergic Neurons, Drosophila, Drosophila melanogaster, Plant Extracts pharmacology, Plant Extracts therapeutic use, Araliaceae, Parkinson Disease drug therapy
- Abstract
Parkinson's disease (PD) is characterized by progressive locomotive defects and loss of dopaminergic neurons. Polyscias fruticosa leaves are used by Vietnamese as herbal medicines to support the treatment of some diseases related to neurodegeneration such as Parkinson's and Alzheimer's diseases. However, recent scientific data have not provided sufficient evidence for the use of P. fruticosa leaves to treat PD or decelerate PD progression. In the present study, the capacity of P. fruticosa leaf extract for PD treatment on the dietary supplementation was investigated using dUCH-knockdown Drosophila model. The results indicated that P. fruticosa leaf extract decelerated dopaminergic neuron degeneration induced by dUCH knockdown in not only the larval stage but also the adult stage, which might result in the amelioration in locomotor ability of dUCH-knockdown larvae and flies. Furthermore, antioxidant activities and some key phytochemicals such as saponins, polyphenols, and flavonoids that might contribute to the effects of the P. fruticosa leaf extract were identified., Competing Interests: The authors declare that there is no conflict of interest regarding the publication of this paper., (Copyright © 2022 Hai Trieu Ly et al.)
- Published
- 2022
- Full Text
- View/download PDF
22. The compensatory reserve index predicts recurrent shock in patients with severe dengue.
- Author
-
Trieu HT, Khanh LP, Ming DKY, Quang CH, Phan TQ, Van VCN, Deniz E, Mulligan J, Wills BA, Moulton S, and Yacoub S
- Subjects
- Blood Pressure physiology, Child, Heart Rate physiology, Humans, Prospective Studies, Severe Dengue diagnosis, Shock diagnosis
- Abstract
Background: Dengue shock syndrome (DSS) is one of the major clinical phenotypes of severe dengue. It is defined by significant plasma leak, leading to intravascular volume depletion and eventually cardiovascular collapse. The compensatory reserve Index (CRI) is a new physiological parameter, derived from feature analysis of the pulse arterial waveform that tracks real-time changes in central volume. We investigated the utility of CRI to predict recurrent shock in severe dengue patients admitted to the ICU., Methods: We performed a prospective observational study in the pediatric and adult intensive care units at the Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam. Patients were monitored with hourly clinical parameters and vital signs, in addition to continuous recording of the arterial waveform using pulse oximetry. The waveform data was wirelessly transmitted to a laptop where it was synchronized with the patient's clinical data., Results: One hundred three patients with suspected severe dengue were recruited to this study. Sixty-three patients had the minimum required dataset for analysis. Median age was 11 years (IQR 8-14 years). CRI had a negative correlation with heart rate and moderate negative association with blood pressure. CRI was found to predict recurrent shock within 12 h of being measured (OR 2.24, 95% CI 1.54-3.26), P < 0.001). The median duration from CRI measurement to the first recurrent shock was 5.4 h (IQR 2.9-6.8). A CRI cutoff of 0.4 provided the best combination of sensitivity and specificity for predicting recurrent shock (0.66 [95% CI 0.47-0.85] and 0.86 [95% CI 0.80-0.92] respectively)., Conclusion: CRI is a useful non-invasive method for monitoring intravascular volume status in patients with severe dengue., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
23. Novel Clinical Monitoring Approaches for Reemergence of Diphtheria Myocarditis, Vietnam.
- Author
-
Chanh HQ, Trieu HT, Vuong HNT, Hung TK, Phan TQ, Campbell J, Pley C, and Yacoub S
- Subjects
- Child, Corynebacterium, Humans, Male, Vietnam epidemiology, Corynebacterium diphtheriae, Diphtheria diagnosis, Diphtheria drug therapy, Diphtheria epidemiology, Myocarditis diagnosis, Myocarditis epidemiology
- Abstract
Diphtheria is a life-threatening, vaccine-preventable disease caused by toxigenic Corynebacterium bacterial species that continues to cause substantial disease and death worldwide, particularly in vulnerable populations. Further outbreaks of vaccine-preventable diseases are forecast because of health service disruptions caused by the coronavirus disease pandemic. Diphtheria causes a spectrum of clinical disease, ranging from cutaneous forms to severe respiratory infections with systemic complications, including cardiac and neurologic. In this synopsis, we describe a case of oropharyngeal diphtheria in a 7-year-old boy in Vietnam who experienced severe myocarditis complications. We also review the cardiac complications of diphtheria and discuss how noninvasive bedside imaging technologies to monitor myocardial function and hemodynamic parameters can help improve the management of this neglected infectious disease.
- Published
- 2022
- Full Text
- View/download PDF
24. Applied machine learning for the risk-stratification and clinical decision support of hospitalised patients with dengue in Vietnam.
- Author
-
Ming DK, Hernandez B, Sangkaew S, Vuong NL, Lam PK, Nguyet NM, Tam DTH, Trung DT, Tien NTH, Tuan NM, Chau NVV, Tam CT, Chanh HQ, Trieu HT, Simmons CP, Wills B, Georgiou P, Holmes AH, and Yacoub S
- Abstract
Background: Identifying patients at risk of dengue shock syndrome (DSS) is vital for effective healthcare delivery. This can be challenging in endemic settings because of high caseloads and limited resources. Machine learning models trained using clinical data could support decision-making in this context., Methods: We developed supervised machine learning prediction models using pooled data from adult and paediatric patients hospitalised with dengue. Individuals from 5 prospective clinical studies in Ho Chi Minh City, Vietnam conducted between 12th April 2001 and 30th January 2018 were included. The outcome was onset of dengue shock syndrome during hospitalisation. Data underwent random stratified splitting at 80:20 ratio with the former used only for model development. Ten-fold cross-validation was used for hyperparameter optimisation and confidence intervals derived from percentile bootstrapping. Optimised models were evaluated against the hold-out set., Findings: The final dataset included 4,131 patients (477 adults and 3,654 children). DSS was experienced by 222 (5.4%) of individuals. Predictors were age, sex, weight, day of illness at hospitalisation, indices of haematocrit and platelets over first 48 hours of admission and before the onset of DSS. An artificial neural network model (ANN) model had best performance with an area under receiver operator curve (AUROC) of 0.83 (95% confidence interval [CI], 0.76-0.85) in predicting DSS. When evaluated against the independent hold-out set this calibrated model exhibited an AUROC of 0.82, specificity of 0.84, sensitivity of 0.66, positive predictive value of 0.18 and negative predictive value of 0.98., Interpretation: The study demonstrates additional insights can be obtained from basic healthcare data, when applied through a machine learning framework. The high negative predictive value could support interventions such as early discharge or ambulatory patient management in this population. Work is underway to incorporate these findings into an electronic clinical decision support system to guide individual patient management., Competing Interests: The authors have declared that no competing interests exist, (Copyright: © 2022 Ming et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2022
- Full Text
- View/download PDF
25. An appraisal of respiratory system compliance in mechanically ventilated covid-19 patients.
- Author
-
Li Bassi G, Suen JY, Dalton HJ, White N, Shrapnel S, Fanning JP, Liquet B, Hinton S, Vuorinen A, Booth G, Millar JE, Forsyth S, Panigada M, Laffey J, Brodie D, Fan E, Torres A, Chiumello D, Corley A, Elhazmi A, Hodgson C, Ichiba S, Luna C, Murthy S, Nichol A, Ng PY, Ogino M, Pesenti A, Trieu HT, and Fraser JF
- Subjects
- Adult, Cohort Studies, Critical Care methods, Europe, Female, Humans, Intensive Care Units, Male, Middle Aged, Retrospective Studies, Severity of Illness Index, COVID-19 complications, COVID-19 therapy, Lung Compliance physiology, Respiration, Artificial methods, Respiratory Distress Syndrome etiology, Respiratory Distress Syndrome therapy
- Abstract
Background: Heterogeneous respiratory system static compliance (C
RS ) values and levels of hypoxemia in patients with novel coronavirus disease (COVID-19) requiring mechanical ventilation have been reported in previous small-case series or studies conducted at a national level., Methods: We designed a retrospective observational cohort study with rapid data gathering from the international COVID-19 Critical Care Consortium study to comprehensively describe CRS -calculated as: tidal volume/[airway plateau pressure-positive end-expiratory pressure (PEEP)]-and its association with ventilatory management and outcomes of COVID-19 patients on mechanical ventilation (MV), admitted to intensive care units (ICU) worldwide., Results: We studied 745 patients from 22 countries, who required admission to the ICU and MV from January 14 to December 31, 2020, and presented at least one value of CRS within the first seven days of MV. Median (IQR) age was 62 (52-71), patients were predominantly males (68%) and from Europe/North and South America (88%). CRS , within 48 h from endotracheal intubation, was available in 649 patients and was neither associated with the duration from onset of symptoms to commencement of MV (p = 0.417) nor with PaO2 /FiO2 (p = 0.100). Females presented lower CRS than males (95% CI of CRS difference between females-males: - 11.8 to - 7.4 mL/cmH2 O p < 0.001), and although females presented higher body mass index (BMI), association of BMI with CRS was marginal (p = 0.139). Ventilatory management varied across CRS range, resulting in a significant association between CRS and driving pressure (estimated decrease - 0.31 cmH2 O/L per mL/cmH2 0 of CRS , 95% CI - 0.48 to - 0.14, p < 0.001). Overall, 28-day ICU mortality, accounting for the competing risk of being discharged within the period, was 35.6% (SE 1.7). Cox proportional hazard analysis demonstrated that CRS (+ 10 mL/cm H2 O) was only associated with being discharge from the ICU within 28 days (HR 1.14, 95% CI 1.02-1.28, p = 0.018)., Conclusions: This multicentre report provides a comprehensive account of CRS in COVID-19 patients on MV. CRS measured within 48 h from commencement of MV has marginal predictive value for 28-day mortality, but was associated with being discharged from ICU within the same period. Trial documentation: Available at https://www.covid-critical.com/study ., Trial Registration: ACTRN12620000421932.- Published
- 2021
- Full Text
- View/download PDF
26. Rapid whole-genome sequencing to inform COVID-19 outbreak response in Vietnam.
- Author
-
Chau NVV, Hong NTT, Ngoc NM, Anh NT, Trieu HT, Nhu LNT, Yen LM, Minh NNQ, Phong NT, Truong NT, Huong LTT, Tu TNH, Hung LM, Thanh TT, Dung NT, Dung NT, Thwaites G, and Van Tan L
- Subjects
- Disease Outbreaks, Humans, SARS-CoV-2, Vietnam epidemiology, Whole Genome Sequencing, COVID-19
- Published
- 2021
- Full Text
- View/download PDF
27. Metformin as adjunctive therapy for dengue in overweight and obese patients: a protocol for an open-label clinical trial (MeDO).
- Author
-
Nguyen NM, Chanh HQ, Tam DTH, Vuong NL, Chau NTX, Chau NVV, Phong NT, Trieu HT, Luong Thi Hue T, Cao Thi T, Dinh The T, Duyen HTL, Van NTT, Nguyen Than Ha Q, Rivino L, Gallagher P, Jones NK, Geskus RB, Kestelyn E, and Yacoub S
- Abstract
Background: Dengue is a disease of major global importance. While most symptomatic infections are mild, a small proportion of patients progress to severe disease with risk of hypovolaemic shock, organ dysfunction and death. In the absence of effective antiviral or disease modifying drugs, clinical management is solely reliant on supportive measures. Obesity is a growing problem among young people in Vietnam and is increasingly recognised as an important risk factor for severe dengue, likely due to alterations in host immune and inflammatory pathways. Metformin, a widely used anti-hyperglycaemic agent with excellent safety profile, has demonstrated potential as a dengue therapeutic in vitro and in a retrospective observational study of adult dengue patients with type 2 diabetes. This study aims to assess the safety and tolerability of metformin treatment in overweight and obese dengue patients, and investigate its effects on several clinical, immunological and virological markers of disease severity. Methods: This open label trial of 120 obese/overweight dengue patients will be performed in two phases, with a metformin dose escalation if no safety concerns arise in phase one. The primary endpoint is identification of clinical and laboratory adverse events. Sixty overweight and obese dengue patients aged 10-30 years will be enrolled at the Hospital for Tropical Diseases in Ho Chi Minh City, Vietnam. Participants will complete a 5-day course of metformin therapy and be compared to a non-treated group of 60 age-matched overweight and obese dengue patients. Discussion: Previously observed antiviral and immunomodulatory effects of metformin make it a promising dengue therapeutic candidate in appropriately selected patients. This study will assess the safety and tolerability of adjunctive metformin in the management of overweight and obese young dengue patients, as well as its effects on markers of viral replication, endothelial dysfunction and host immune responses. Trial registration: ClinicalTrials.gov: NCT04377451 (May 6
th 2020)., Competing Interests: No competing interests were disclosed., (Copyright: © 2021 Nguyen NM et al.)- Published
- 2021
- Full Text
- View/download PDF
28. Tecticornia sp. (Samphire)-A Promising Underutilized Australian Indigenous Edible Halophyte.
- Author
-
Srivarathan S, Phan ADT, Hong HT, Chua ET, Wright O, Sultanbawa Y, and Netzel ME
- Abstract
Salinization is gradually increasing over cropping soils and is challenging Governments in many countries, including Australia. There has been a high demand for utilizing arid and semi-arid land for sustainable food production. Currently, the main crops and forage plants are salt sensitive, while halophytes can tolerate a wide range of salinities. Samphire is an Australian indigenous edible halophyte and belongs to the genus Tecticornia . It is an underutilized, succulent plant growing on arid or semi-arid land. Most samphire species have a long history of use as food, but also as non-food (fodder and medicine), among indigenous communities in Australia, while scientific information is limited on their nutritional composition and potential bioactivity. The present study reports, for the first time, the nutritional composition, bioactive compounds (phytochemicals) and antioxidant capacity of six Australian grown samphire from different locations. The results showed that celosianin II and isocelosianin II could be identified as the predominant betalains (phytochemicals) in pigmented samphire species. Proximates and fiber varied significantly ( p < 0.05) between the samphire species with a highest value of fiber of 46.8 g/100 g dry weight (DW). Furthermore, samphire could be identified as a valuable source of essential minerals and trace elements, such as iron (41.5 mg/100 g DW), magnesium (1.2 g/100 g DW) and sodium (16.7 g/100 g DW). The fatty acid profile, mainly palmitic, stearic, oleic, linoleic and α-linolenic acid, was similar among the studied species. Total phenolic content and DPPH-radical scavenging capacity were different ( p < 0.05) between the six samphire samples. These initial results are very promising and indicate that Australian grown samphire may have the potential to be utilized as a functional food ingredient., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Srivarathan, Phan, Hong, Chua, Wright, Sultanbawa and Netzel.)
- Published
- 2021
- Full Text
- View/download PDF
29. Microvascular Fluid Exchange: Implications of the Revised Starling Model for Resuscitation of Dengue Shock Syndrome.
- Author
-
Trung DT, Trieu HT, and Wills BA
- Abstract
Dengue is the most common mosquito-borne viral infection in the world. The most feared complication is a poorly understood vasculopathy that occurs in only a small minority of symptomatic individuals, especially children and young adults, but can result in potentially fatal dengue shock syndrome (DSS). Based mainly on expert opinion, WHO management guidelines for DSS recommend prompt infusion of a crystalloid fluid bolus followed by a tapering crystalloid fluid regimen, supplemented if necessary by boluses of synthetic colloid solutions. However, following publication of a number of major trials undertaken in other, primarily adult, critical care scenarios, use of both synthetic colloid solutions and of fluid boluses for volume expansion have become controversial. Synthetic colloids tend to be used for severe DSS cases in order to boost intravascular oncotic pressure, based on the classic Starling hypothesis in which opposing hydrostatic and oncotic forces determine fluid flow across the microvascular barrier. However, the revised Starling model emphasizes the critical contribution of the endothelial glycocalyx layer (EGL), indicating that it is the effective oncotic pressure gradient across the EGL not endothelial cells per se that opposes filtration. Based on several novel concepts that are integral to the revised Starling model, we review the clinical features of DSS and discuss a number of implications that are relevant for fluid management. We also highlight the need for context-specific clinical trials that address crucially important questions around the management of DSS., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2020 Trung, Trieu and Wills.)
- Published
- 2020
- Full Text
- View/download PDF
30. Assessing the virulence of Cryptococcus neoformans causing meningitis in HIV infected and uninfected patients in Vietnam.
- Author
-
Thanh LT, Toffaletti DL, Tenor JL, Giamberardino C, Sempowski GD, Asfaw Y, Phan HT, Van Duong A, Trinh NM, Thwaites GE, Ashton PM, Chau NVV, Baker SG, Perfect JR, and Day JN
- Subjects
- AIDS-Related Opportunistic Infections pathology, Animals, Colony Count, Microbial, Cryptococcus neoformans genetics, Cytokines metabolism, Female, Fungal Capsules pathology, Genotype, Humans, Immunocompetence, Lung metabolism, Lung microbiology, Lung pathology, Male, Meningitis, Cryptococcal pathology, Mice, Phenotype, Vietnam epidemiology, Virulence, AIDS-Related Opportunistic Infections microbiology, Cryptococcus neoformans pathogenicity, Meningitis, Cryptococcal microbiology
- Abstract
We previously observed a substantial burden of cryptococcal meningitis in Vietnam atypically arising in individuals who are uninfected with human immunodeficiency virus (HIV). This disease was associated with a single genotype of Cryptococcus neoformans (sequence type [ST]5), which was significantly less common in HIV-infected individuals. Aiming to compare the phenotypic characteristics of ST5 and non-ST5 C. neoformans, we selected 30 representative Vietnamese isolates and compared their in vitro pathogenic potential and in vivo virulence. ST5 and non-ST5 organisms exhibited comparable characteristics with respect to in vitro virulence markers including melanin production, replication at 37°C, and growth in cerebrospinal fluid. However, the ST5 isolates had significantly increased variability in cellular and capsular sizing compared with non-ST5 organisms (P < .001). Counterintuitively, mice infected with ST5 isolates had significantly longer survival with lower fungal burdens at day 7 than non-ST5 isolates. Notably, ST5 isolates induced significantly greater initial inflammatory responses than non-ST5 strains, measured by TNF-α concentrations (P < .001). Despite being generally less virulent in the mouse model, we hypothesize that the significant within strain variation seen in ST5 isolates in the tested phenotypes may represent an evolutionary advantage enabling adaptation to novel niches including apparently immunocompetent human hosts., (© The Author(s) 2020. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.)
- Published
- 2020
- Full Text
- View/download PDF
31. Metformin as adjunctive therapy for dengue in overweight and obese patients: a protocol for an open-label clinical trial (MeDO).
- Author
-
Nguyen NM, Chanh HQ, Tam DTH, Vuong NL, Chau NTX, Chau NVV, Phong NT, Trieu HT, Luong Thi Hue T, Cao Thi T, Dinh The T, Duyen HTL, Van NTT, Nguyen Than Ha Q, Rivino L, Gallagher P, Jones NK, Geskus RB, Kestelyn E, and Yacoub S
- Abstract
Background: Dengue is a disease of major global importance. While most symptomatic infections are mild, a small proportion of patients progress to severe disease with risk of hypovolaemic shock, organ dysfunction and death. In the absence of effective antiviral or disease modifying drugs, clinical management is solely reliant on supportive measures. Obesity is a growing problem among young people in Vietnam and is increasingly recognised as an important risk factor for severe dengue, likely due to alterations in host immune and inflammatory pathways. Metformin, a widely used anti-hyperglycaemic agent with excellent safety profile, has demonstrated potential as a dengue therapeutic in vitro and in a retrospective observational study of adult dengue patients with type 2 diabetes. This study aims to assess the safety and tolerability of metformin treatment in overweight and obese dengue patients, and investigate its effects on several clinical, immunological and virological markers of disease severity. Methods: This open label trial of 120 obese/overweight dengue patients will be performed in two phases, with a metformin dose escalation if no safety concerns arise in phase one. The primary endpoint is identification of clinical and laboratory adverse events. Sixty overweight and obese dengue patients aged 10-30 years will be enrolled at the Hospital for Tropical Diseases in Ho Chi Minh City, Vietnam. Participants will complete a 5-day course of metformin therapy and be compared to a non-treated group of 60 age-matched overweight and obese dengue patients. Discussion: Previously observed antiviral and immunomodulatory effects of metformin make it a promising dengue therapeutic candidate in appropriately selected patients. This study will assess the safety and tolerability of adjunctive metformin in the management of overweight and obese young dengue patients, as well as its effects on markers of viral replication, endothelial dysfunction and host immune responses. Trial registration: ClinicalTrials.gov: NCT04377451 (May 6
th 2020)., Competing Interests: No competing interests were disclosed., (Copyright: © 2020 Nguyen NM et al.)- Published
- 2020
- Full Text
- View/download PDF
32. Nutritional Value and Antimicrobial Activity of Pittosporum angustifolium (Gumby Gumby), an Australian Indigenous Plant.
- Author
-
Phan ADT, Chaliha M, Hong HT, Tinggi U, Netzel ME, and Sultanbawa Y
- Abstract
The indigenous endemic plant P. angustifolium has received attention for nutraceutical and therapeutic applications in Australia. This study investigates for the first time the nutritional value (macro- and micronutrients, minerals, trace elements, polyphenols, carotenoids, saponins and antioxidant capacity) and antimicrobial activity of different botanical parts of P. angustifolium , either collected from the wild or cultivated. Different botanical tissues, geographic location and growing condition (wild vs. cultivated) showed significant ( p < 0.05) effects on the tested bioactive compounds, with the leaves having significantly ( p < 0.05) higher levels than the stems. Saponins and polyphenols could be identified as the main bioactive compounds in the leaves with up to 4% per dry weight. The extracts of P. angustifolium leaves and stems showed strong antioxidant and antimicrobial activities, especially against Candida albicans . These activities correlated (R
2 = 0.64-0.92; p < 0.05) with the levels of polyphenols and saponins, indicating their biologic potential. Findings from this study may provide information for future applications of P. angustifolium in the functional ingredient or nutraceutical industry.- Published
- 2020
- Full Text
- View/download PDF
33. Sargassumhorneri extracts stimulate innate immunity, enhance growth performance, and upregulate immune genes in the white shrimp Litopenaeus vannamei.
- Author
-
Lee PT, Quan Tran HT, Huang HT, Nan FH, and Lee MC
- Subjects
- Animals, Arthropod Proteins genetics, Arthropod Proteins immunology, Dose-Response Relationship, Drug, Immunity, Innate drug effects, Penaeidae drug effects, Penaeidae growth & development, Random Allocation, Up-Regulation drug effects, Immunity, Innate genetics, Penaeidae genetics, Penaeidae immunology, Sargassum chemistry, Up-Regulation immunology
- Abstract
The white shrimp Litopenaeus vannamei is one of the most commercially important aquatic species. However, intensive farming to meet economic demands has been linked to animal stress and subsequent disease outbreaks. In this study, we explore the immunomodulatory effects of Sargassum horneri hot-water extract (SHE) on the immune parameters of L. vannamei. Hemocytes incubated in vitro with 10 mg/ml of SHE showed the highest response in phenoloxidase (PO) activity and reactive oxygen species production. In the in vivo trials, shrimp were fed diets containing 0 (control), 2.5 (SHE 2.5), 5.0 g (SHE 5.0), and 10 g (SHE10.0) of lyophilized SHE per kg feed for four weeks, after which immune parameters were measured. Group SHE10.0 had the highest total hemocyte count, reactive oxygen species production, and phagocytic rate during the 4-week feeding period, followed by groups SHE5.0 and SHE2.5. However, group SHE5.0 showed a better growth performance among all examined groups after four weeks of rearing. Furthermore, gene expression analysis revealed that L. vannamei fed diets containing 0.5% SHE over 28 days showed significant modulation of 11 immune-related genes, including prophenoloxidase I, prophenoloxidase II, peroxinectin, α2macroglobulin, clotting protein, lysozyme, superoxide dismutase, glutathione peroxidase, penaiedin2-4, and crustin. Combined, these results show that SHE is a functional feed additive that can be applied orally to enhance innate immunity and growth performance of white shrimps., Competing Interests: Declaration of competing interest The authors declare that they have no conflicts of interest., (Copyright © 2020 Elsevier Ltd. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
34. Bufalin reverses multidrug resistance by regulating stemness through the CD133/nuclear factor-κB/MDR1 pathway in colorectal cancer.
- Author
-
Zhan Y, Qiu Y, Wang H, Wang Z, Xu J, Fan G, Xu J, Li W, Cao Y, Le VM, Ly HT, Yuan Z, Xu K, and Yin P
- Subjects
- AC133 Antigen genetics, ATP Binding Cassette Transporter, Subfamily B genetics, ATP Binding Cassette Transporter, Subfamily B metabolism, Animals, Antineoplastic Agents therapeutic use, Bufanolides therapeutic use, Cell Line, Tumor, Colorectal Neoplasms drug therapy, Colorectal Neoplasms metabolism, Doxorubicin pharmacology, Doxorubicin therapeutic use, Drug Resistance, Multiple drug effects, Drug Therapy, Combination, Gene Expression Regulation, Neoplastic drug effects, Humans, Mice, Mice, Nude, Neoplastic Stem Cells drug effects, Neoplastic Stem Cells metabolism, Neoplastic Stem Cells pathology, Signal Transduction, Transcription Factor RelA genetics, AC133 Antigen metabolism, Antineoplastic Agents pharmacology, Bufanolides pharmacology, Colorectal Neoplasms pathology, Drug Resistance, Neoplasm drug effects, Transcription Factor RelA metabolism
- Abstract
Recent studies have shown that MDR could be induced by the high stemness of cancer cells. In a previous study, we found bufalin could reverse MDR and inhibit cancer cell stemness in colorectal cancer, but the relationship between them was unclear. Here we identified overexpressing CD133 increases levels of Akt/nuclear factor-κB signaling mediators and MDR1, while increasing cell chemoresistance. Furthermore, bufalin reverses colorectal cancer MDR by regulating cancer cell stemness through the CD133/nuclear factor-κB/MDR1 pathway in vitro and in vivo. Taken together, our results suggest that bufalin could be developed as a novel 2-pronged drug that targets CD133 and MDR1 to eradicate MDR cells and could ultimately be combined with conventional chemotherapeutic agents to improve treatment outcomes for patients with colorectal cancer., (© 2020 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.)
- Published
- 2020
- Full Text
- View/download PDF
35. A dataset for anthocyanin analysis in purple-pericarp sweetcorn kernels by LC-DAD-MS.
- Author
-
Hong HT, Netzel ME, and O'Hare TJ
- Abstract
This dataset refers to the accompanying article "Optimization of extraction procedure and development of LC-DAD-MS methodology for anthocyanin analysis in anthocyanin-pigmented corn kernels", published in Food Chemistry [1]. Here, we present concentrations, profiles, MS
2 spectra of individual anthocyanins (including isomers of cyanidin-3-(6''-malonylglucoside)) of purple-pericarp sweetcorn (PPS) kernels. Furthermore, an additional mass spectrum of an artefact-anthocyanin produced in acidified extraction solutions were reported. This data is further discussed in the accompanying research article [1]. Delphinidin-3-glucoside was used as an internal standard to compensate for individual anthocyanin losses during extraction with acidified solutions. The generated data could be used for anthocyanin identification and quantification in different anthocyanin-containing plant matrices., (© 2020 The Author(s).)- Published
- 2020
- Full Text
- View/download PDF
36. Targeting CD133 reverses drug-resistance via the AKT/NF-κB/MDR1 pathway in colorectal cancer.
- Author
-
Yuan Z, Liang X, Zhan Y, Wang Z, Xu J, Qiu Y, Wang J, Cao Y, Le VM, Ly HT, Xu J, Li W, Yin P, and Xu K
- Subjects
- ATP Binding Cassette Transporter, Subfamily B genetics, Apoptosis drug effects, Cell Line, Tumor, Cell Proliferation drug effects, Colorectal Neoplasms genetics, Colorectal Neoplasms pathology, Drug Resistance, Neoplasm genetics, Gene Expression Regulation, Neoplastic drug effects, Humans, NF-kappa B genetics, Proto-Oncogene Proteins c-akt genetics, Signal Transduction drug effects, Transcription Factor RelA genetics, AC133 Antigen genetics, Colorectal Neoplasms drug therapy, Doxorubicin pharmacology
- Abstract
Background: Recent studies have shown that multidrug resistance may be induced by the high stemness of cancer cells. Following prolonged chemotherapy, MDR protein 1 (MDR1) and CD133 increase in CRC, but the relationship between them is unclear., Methods: The relationship between MDR and CSC properties in CRC was determined via CCK-8 assay, apoptosis assay, DOX uptake and retention, immunohistochemistry, immunofluorescence and flow cytometry. The correlations between their expression levels were evaluated using Spearman's rank statistical test and the Mann-Whitney test. Furthermore, the effect of CD133 on the repression of the AKT/NF-κB/MDR1 signalling pathway was investigated in vitro and in vivo., Results: We found that CD133 increased with the emergence of drug-resistance phenotypes, and the high expression of MDR1/P-gp was consistently accompanied by positive expression of CD133 as demonstrated by the analysis of patient samples. Up- or downregulation of CD133 could regulate MDR via AKT/NF-κB/MDR1 signalling in CRC. A rescue experiment showed that the AKT/NF-κB signalling pathway is the main mechanism by which CD133 regulates MDR1/P-gp expression in CRC., Conclusions: Taken together, our results suggest that targeting CD133 reverses drug resistance via the AKT/NF-κB/MDR1 pathway and that this pathway might serve as a potential therapeutic target to reverse MDR in CRC.
- Published
- 2020
- Full Text
- View/download PDF
37. Long-term outcome in survivors of neonatal tetanus following specialist intensive care in Vietnam.
- Author
-
Trieu HT, Anh NTK, Vuong HNT, Dao TTM, Hoa NTX, Tuong VNC, Dinh PT, Wills B, Qui PT, Van Tan L, Yen LM, Sabanathan S, and Thwaites CL
- Subjects
- Case-Control Studies, Child, Child, Preschool, Female, Follow-Up Studies, Humans, Intensive Care Units, Neonatal, Male, Survivors, Tetanus complications, Vietnam, Developmental Disabilities etiology, Tetanus therapy
- Abstract
Background: Neonatal tetanus continues to occur in many resource-limited settings but there are few data regarding long-term neurological outcome from the disease, especially in settings with critical care facilities., Methods: We assessed long-term outcome following neonatal tetanus in infants treated in a pediatric intensive care unit in southern Vietnam. Neurological and neurodevelopmental testing was performed in 17 survivors of neonatal tetanus and 18 control children from the same communities using tools previously validated in Vietnamese children., Results: The median age of children assessed was 36 months. Eight neonatal tetanus survivors and 9 community control cases aged < 42 months were tested using the Bayley III Scales of Infant and Toddler Development (Bayley III-VN) and 8 neonatal tetanus survivors and 9 community controls aged ≥42 months were tested using the Movement Assessment Battery for Children. No significant reductions in growth indices or neurodevelopmental scores were shown in survivors of neonatal tetanus compared to controls although there was a trend towards lower scores in neonatal tetanus survivors. Neurological examination was normal in all children except for two neonatal tetanus survivors with perceptive deafness and one child with mild gross motor abnormality. Neonatal tetanus survivors who had expienced severe disease (Ablett grade ≥ 3) had lower total Bayley III-VN scores than those with mild disease (15 (IQR 14-18) vs 24 (IQR 19-27), p = 0.05) with a significantly lower cognitive domain score (3 (IQR 2-6) severe disease vs 7 (IQR 7-8) mild disease, p = 0.02)., Conclusions: Neonatal tetanus is associated with long-term sequelae in those with severe disease. In view of these findings, prevention of neonatal tetanus should remain a priority.
- Published
- 2017
- Full Text
- View/download PDF
38. Neonatal Tetanus in Vietnam: Comprehensive Intensive Care Support Improves Mortality.
- Author
-
Trieu HT, Lubis IN, Qui PT, Yen LM, Wills B, Thwaites CL, and Sabanathan S
- Subjects
- Anti-Bacterial Agents therapeutic use, Blood Pressure Determination, Humans, Hypnotics and Sedatives therapeutic use, Infant, Newborn, Magnesium Sulfate therapeutic use, Monitoring, Physiologic methods, Neuromuscular Agents therapeutic use, Positive-Pressure Respiration, Retrospective Studies, Tetanus drug therapy, Vietnam epidemiology, Critical Care methods, Tetanus mortality, Tetanus therapy
- Abstract
We report a 66% reduction in neonatal tetanus mortality after introducing a new management bundle integrating antibiotic therapy, muscle relaxation and invasive monitoring. The latter allowed rapid detection of autonomic instability which was treated with magnesium sulphate. This is the first report of its use in neonatal tetanus., (© The Author 2015. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society.)
- Published
- 2016
- Full Text
- View/download PDF
39. Intravenous magnesium sulfate for the management of severe hand, foot, and mouth disease with autonomic nervous system dysregulation in Vietnamese children: study protocol for a randomized controlled trial.
- Author
-
Qui PT, Khanh TH, Trieu HT, Giang PT, Bich NN, Thoa le PK, Nhan le NT, Sabanathan S, Van Doorn R, Toan ND, Merson L, Dung NT, Khanh LP, Wolbers M, Hung NT, Chau NV, and Wills B
- Subjects
- Data Interpretation, Statistical, Double-Blind Method, Hand, Foot and Mouth Disease complications, Humans, Informed Consent, Injections, Intravenous, Magnesium Sulfate adverse effects, Milrinone administration & dosage, Sample Size, Autonomic Nervous System Diseases drug therapy, Clinical Protocols, Hand, Foot and Mouth Disease drug therapy, Magnesium Sulfate administration & dosage
- Abstract
Background: Over the last 15 years, hand, foot, and mouth disease (HFMD) has emerged as a major public health burden across the Asia-Pacific region. A small proportion of HFMD patients, typically those infected with enterovirus 71 (EV71), develop brainstem encephalitis with autonomic nervous system (ANS) dysregulation and may progress rapidly to cardiopulmonary failure and death. Although milrinone has been reported to control hypertension and support myocardial function in two small studies, in practice, a number of children still deteriorate despite this treatment. Magnesium sulfate (MgSO4) is a cheap, safe, and readily available medication that is effective in managing tetanus-associated ANS dysregulation and has shown promise when used empirically in EV71-confirmed severe HFMD cases., Methods/design: We describe the protocol for a randomized, placebo-controlled, double-blind trial of intravenous MgSO4 in Vietnamese children diagnosed clinically with HFMD plus ANS dysregulation with systemic hypertension. A loading dose of MgSO4 or identical placebo is given over 20 min followed by a maintenance infusion for 72 h according to response, aiming for Mg levels two to three times the normal level in the treatment arm. The primary endpoint is a composite of disease progression within 72 h defined as follows: development of pre-specified blood pressure criteria necessitating the addition of milrinone, the need for ventilation, shock, or death. Secondary endpoints comprise these parameters singly, plus other clinical endpoints including the following: requirement for other inotropic agents; duration of hospitalization; presence of neurological sequelae at discharge in survivors; and neurodevelopmental status assessed 6 months after discharge. The number and severity of adverse events observed in the two treatment arms will also be compared. Based on preliminary data from a case series, and allowing for some losses, 190 patients (95 in each arm) will allow detection of a 50 % reduction in disease progression with 90 % power at a two-sided 5 % significance level., Discussion: Given the large numbers of HFMD cases currently being seen in hospitals in Asia, if MgSO4 is shown to be effective in controlling ANS dysregulation and preventing severe HFMD complications, this finding would be important to pediatric care throughout the region., Trial Registration: ClinicalTrials.gov Identifier: NCT01940250 (Registered 22 August 2013).
- Published
- 2016
- Full Text
- View/download PDF
40. Prognosis of neonatal tetanus in the modern management era: an observational study in 107 Vietnamese infants.
- Author
-
Lam PK, Trieu HT, Lubis IN, Loan HT, Thuy TT, Wills B, Parry CM, Day NP, Qui PT, Yen LM, and Thwaites CL
- Subjects
- Female, Humans, Infant, Newborn, Male, Prognosis, Risk Factors, Tetanus diagnosis, Vietnam, Tetanus mortality
- Abstract
Objectives: Most data regarding the prognosis in neonatal tetanus originate from regions where limited resources have historically impeded management. It is not known whether recent improvements in critical care facilities in many low- and middle-income countries have affected indicators of a poor prognosis in neonatal tetanus. We aimed to determine the factors associated with worse outcomes in a Vietnamese hospital with neonatal intensive care facilities., Methods: Data were collected from 107 cases of neonatal tetanus. Clinical features on admission were analyzed against mortality and a combined endpoint of 'death or prolonged hospital stay'., Results: Multivariable analysis showed that only younger age (odds ratio (OR) for mortality 0.69, 95% confidence interval (CI) 0.48-0.98) and lower weight (OR for mortality 0.06, 95% CI 0.01-0.54) were significantly associated with both the combined endpoint and death. A shorter period of onset (OR 0.94, 95% CI 0.88-0.99), raised white cell count (OR 1.17, 95% CI 1.02-1.35), and time between first symptom and admission (OR 3.77, 95% CI 1.14-12.51) were also indicators of mortality., Conclusions: Risk factors for a poor outcome in neonatal tetanus in a setting with critical care facilities include younger age, lower weight, delay in admission, and leukocytosis., (Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
41. Functional range of movement of the hand: declination angles to reachable space.
- Author
-
Pham HT, Pathirana PN, and Caelli T
- Subjects
- Adult, Fingers physiology, Humans, Joints physiology, Male, Pinch Strength physiology, Task Performance and Analysis, Hand physiology, Movement physiology, Range of Motion, Articular physiology
- Abstract
The measurement of the range of hand joint movement is an essential part of clinical practice and rehabilitation. Current methods use three finger joint declination angles of the metacarpophalangeal, proximal interphalangeal and distal interphalangeal joints. In this paper we propose an alternate form of measurement for the finger movement. Using the notion of reachable space instead of declination angles has significant advantages. Firstly, it provides a visual and quantifiable method that therapists, insurance companies and patients can easily use to understand the functional capabilities of the hand. Secondly, it eliminates the redundant declination angle constraints. Finally, reachable space, defined by a set of reachable fingertip positions, can be measured and constructed by using a modern camera such as Creative Senz3D or built-in hand gesture sensors such as the Leap Motion Controller. Use of cameras or optical-type sensors for this purpose have considerable benefits such as eliminating and minimal involvement of therapist errors, non-contact measurement in addition to valuable time saving for the clinician. A comparison between using declination angles and reachable space were made based on Hume's experiment on functional range of movement to prove the efficiency of this new approach.
- Published
- 2014
- Full Text
- View/download PDF
42. Adaptive shared control strategies based in the Bayesian recursive technique in an intelligent wheelchair.
- Author
-
Trieu HT, Willey K, and Nguyen HT
- Subjects
- Biomedical Engineering, Equipment Design, Humans, Artificial Intelligence, Bayes Theorem, Wheelchairs statistics & numerical data
- Abstract
In this paper we present an adaptive shared control method for an intelligent wheelchair based on the Bayesian recursive technique to assist a disable user in performing obstacle avoidance tasks. Three autonomous tasks have been developed for different types of environments to improve the performance of the overall system. The system combines local environmental information gathered using a laser range finder sensor with the user's intentions to select the most suitable autonomous task in different situations. The evidences of these tasks are estimated by the Bayesian recursive technique during movements of the wheelchair. The most appropriate task is chosen to be the with the highest evidence value. Experimental results show significant performance improvements compared to our previously reported shared control methods.
- Published
- 2009
- Full Text
- View/download PDF
43. Advanced obstacle avoidance for a laser based wheelchair using optimised Bayesian neural networks.
- Author
-
Trieu HT, Nguyen HT, and Willey K
- Subjects
- Algorithms, Artificial Intelligence, Avoidance Learning, Bayes Theorem, Equipment Design, Humans, Man-Machine Systems, Models, Statistical, Movement, Neural Networks, Computer, Pattern Recognition, Automated, Robotics, Self-Help Devices, Wheelchairs, Persons with Disabilities rehabilitation
- Abstract
In this paper we present an advanced method of obstacle avoidance for a laser based intelligent wheelchair using optimized Bayesian neural networks. Three neural networks are designed for three separate sub-tasks: passing through a door way, corridor and wall following and general obstacle avoidance. The accurate usable accessible space is determined by including the actual wheelchair dimensions in a real-time map used as inputs to each networks. Data acquisitions are performed separately to collect the patterns required for specified sub-tasks. Bayesian frame work is used to determine the optimal neural network structure in each case. Then these networks are trained under the supervision of Bayesian rule. Experiment results showed that compare to the VFH algorithm our neural networks navigated a smoother path following a near optimum trajectory.
- Published
- 2008
- Full Text
- View/download PDF
44. Shared control strategies for obstacle avoidance tasks in an intelligent wheelchair.
- Author
-
Trieu HT, Nguyen HT, and Willey K
- Subjects
- Algorithms, Avoidance Learning, Bayes Theorem, Calibration, Equipment Design, Feedback, Humans, Man-Machine Systems, Models, Statistical, Neural Networks, Computer, Personal Autonomy, Reproducibility of Results, Task Performance and Analysis, Persons with Disabilities rehabilitation, Wheelchairs
- Abstract
In this paper we present a method of shared control strategy for an intelligent wheelchair to assist a disable user in performing obstacle avoidance tasks. The system detects obstacles in front of the wheelchair using a laser range finder sensor. As the wheelchair moves the information from the laser range finder is combined with data from the encoders mounted in its driving wheels to build a 360 degrees real-time map. The accuracy of the map is improved by eliminating the systematic error that would result from both the uncertainty of effective wheelbase and unequal driving wheel diameters. The usable wheelchair accessible space is determined by including the actual wheelchair dimensions in producing the real-time map. In making a decision the shared control method considers the user's intentions via the head-movement interface, accessible space of the environment and user safety. The experiments show promising results in the intelligent wheelchair system.
- Published
- 2008
- Full Text
- View/download PDF
45. Safety and outcomes of laparoscopic gastric bypass surgery in patients 60 years of age and older.
- Author
-
Trieu HT, Gonzalvo JP, Szomstein S, and Rosenthal R
- Subjects
- Age Factors, Aged, Anastomosis, Roux-en-Y, Body Mass Index, Female, Humans, Male, Middle Aged, Postoperative Complications, Retrospective Studies, Safety, Treatment Outcome, Gastric Bypass methods, Laparoscopy, Obesity, Morbid surgery
- Abstract
Background: Many surgeons are hesitant to offer bariatric surgery to patients >60 years of age because of concern of the considerably greater perioperative risk and less weight-control efficacy. We hypothesized that laparoscopic Roux-en-Y gastric bypass (LRYGB) can be performed in this patient population with acceptable morbidity and can achieve effective weight control., Methods: A retrospective review was performed of patients >60 years of age who had undergone LRYGB at the Bariatric Institute at Cleveland Clinic Florida from 2001 to 2004. The data assessed included age, gender, preoperative and postoperative weight and body mass index (BMI), and postoperative complications., Results: A total of 92 patients >60 years who had undergone LRYGB were reviewed in this study. The mean preoperative weight and BMI was 136.6 kg and 48.4 kg/m(2), respectively. The mean postoperative weight and BMI was 100.3 kg and 35.9 kg/m(2), respectively. The mean percentage of excess weight loss was 53.85%. The early complications were an anastomotic leak in 2 patients (2.2%), intraluminal hemorrhage in 1 patient (1.1%), pulmonary embolus in 1 patient (1.1%), pneumonia in 1 patient (1.1%), and atrial fibrillation in 1 patient (1.1%). The late complications included stenosis at the gastrojejunostomy in 8 patients (8.6%), marginal ulceration in 3 (3.2%), small bowel obstruction in 1 (1.1%), internal hernia in 1 (1.1%), and abdominal wall hernia in 1. No mortality occurred., Conclusion: LRYGB can be performed safely and can achieve effective weight control in patients >60 years of age.
- Published
- 2007
- Full Text
- View/download PDF
46. Obstacle avoidance for power wheelchair using bayesian neural network.
- Author
-
Trieu HT, Nguyen HT, and Willey K
- Subjects
- Algorithms, Bayes Theorem, Humans, Avoidance Learning, Persons with Disabilities rehabilitation, Equipment Design, Wheelchairs
- Abstract
In this paper we present a real-time obstacle avoidance algorithm using a Bayesian neural network for a laser based wheelchair system. The raw laser data is modified to accommodate the wheelchair dimensions, allowing the free-space to be determined accurately in real-time. Data acquisition is performed to collect the patterns required for training the neural network. A Bayesian frame work is applied to determine the optimal neural network structure for the training data. This neural network is trained under the supervision of the Bayesian rule and the obstacle avoidance task is then implemented for the wheelchair system. Initial results suggest this approach provides an effective solution for autonomous tasks, suggesting Bayesian neural networks may be useful for wider assistive technology applications.
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.